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ABSTRACT OF DISSERTATION

DESIGNING MOLECULAR RECOGNITION IN THE CONTEXT OF
HYDROGEN BONDING AND MOLECULAR DYNAMICS

The effect of hydrogen bonding on the conformation of organic molecules
unifies two projects in this thesis. In one project, the stability of the intramolecular
hydrogen bond in derivatives of 2-guanidinobenzimidazole was studied by
dynamic 1H NMR spectrometry. The impact that this intramolecular hydrogen
bond had on the bond order of the neutral guanidino group and on the dynamic
conformation of these aromatic structures was related to the concept of hydrogen
bond-assisted resonance. In another project, an oligomer possessing repetitive
conformation and capable of much inter- and intramolecular hydrogen bonding
was designed and synthesized. The sensitivity of this oligomer to changes in
anion concentration, as well as its own propensity to self-aggregate were
measured.
Hydrogen bonds found in many biological oligomers are connected though
a system of conjugated bonds. Guanidinobenzimidazole is a conjugated system
of carbon and nitrogen, connected by an intramolecular hydrogen bond. Several

derivatives of guanidinobenzimidazole were synthesized, and the effect of
several

simple

alkyl

for

hydrogen

substitutions

were

studied.

Guanidinobenzimidazole was used as a model to study what effect the
conjugation and the intramolecular hydrogen bond have on each other.

The formation of redundant low energy hydrogen bonds is universal in
biological oligomers. In DNA and RNA multiple hydrogen bonds are formed with
a typical energy contribution of only 1-2 kcal/mol. Individually, these interactions
do not give the biological oligomers their conformational stability, but together
they are very stable. The urea and amide based oligomers designed in the work
and discussed in the thesis should form multiple hydrogen bonds with
themselves and/or with anionic guests. Chiral oligoureas were designed to
possess this characteristic of cooperative conformation that so many biological
oligomers and polymers share.
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Chapter 1
A model system for intramolecular hydrogen bonds
connected through a conjugated heteroatom system
1.1 Overview
The theme of this thesis is the exploration of hydrogen bonds as a
controlling factor in the conformation of organic molecules. In most biological
systems, including protein and DNA, hydrogen bonds help to form the complex
biological structures necessary to sustain life. Regarding hydrogen bonding in
protein and DNA, other factors including steric control lead to complex
substructures including the α-helix, β-sheet and in DNA, the double helix. An
understanding of the mechanisms and patterns involved in hydrogen bonding is
crucial to the ability to understand and modify the activity of these biological
structures.
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Figure 1.1 1,5-Diaminoaromatic structures
In the first part of the thesis, the reader will encounter a detailed analysis
of the energetic contribution to overall conformational stability of six-centered
intramolecular hydrogen bonds in nitrogen-based aromatic systems, which can
have more than one tautomeric form. In this type of system the rate of hydrogen
atom exchange is important because hydrogen atom exchange converts one
tautomer to another. Furthermore, the hydrogen atom exchange tautomers
possess different bond orders. A double bond greatly impedes bond rotation
whereas a single bond allows bond rotation.
In chapter two there is a discussion on the details of syntheses of 2aminobenzimidazole derivatives. These syntheses uses 2-aminobenzimidazole
and 1,2-phenylenediamine with electrophiles including carbodiimides and dialkyldicyandiamides (N,N-dialkyl-dicyandiamides). The synthesis of these compounds
was facile and included only one or two synthetic steps to get from a commercial
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product to the desired chemical. In most cases only required crystallization for
purification. For 1g an initial purification was done, by column and a subsequent
crystallization was required due to the tendency of these compounds to streak on
the column.
In Chapter three this thesis moves from a problem in minute analysis to a
problem in the global design of a family of oligomers (oligoureas) that can take
on hydrogen bond-dependent conformations. The effort was directed toward the
mimicry of the peptide backbone in its ability to bind anionic guests as in the case
of sulfate6,29 and phosphate binding proteins. Since it is the N-H contacts in the
phosphate binding protein that stabilize the enfolded anions,26 we reasoned that
oligoureas should do this better. Oligoureas have twice as many N-H hydrogen
bond donors per residue than the peptide chain. The work in this thesis scratches
the surface of the full potential of this project to flower into a comprehensive
study. Forays were made into the synthesis of the desired materials. Using the
conformation and intermolecular hydrogen bonding in a crystal structure of a
dimer as a footstool, we extrapolated to the conformation of extended structures
using molecular modeling. Some physical studies (nuclear magnetic resonance
spectrometry and circular dichroism spectrometry) were also performed to assay
the hydrogen bonding interactions between oxo-anions and oligoureas.
Before we began this work there was discrepancy in the literature
regarding the presence of an intramolecular hydrogen bond in
guanidinobenzimidazole. In our studies we found indirect evidence for the
existence of a weak, intramolecular hydrogen bond in guanidinobenzimidazole
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through a study of derivatives for this molecule. Because this hydrogen bond is
weak hydrogen atom exchange is an important phenomena in the control of the
rate of hydrogen bond cleavage. The relative rates of exchange processes in
guanidinobenzimidazole is therefore very solvent dependent.
In the other theme of this thesis, interactions between de novo oligomers
and anions were studied by modeling and a few binding assays of various
derivatives to determine the influence of the shape and conformation of the
monomer units on the shape and resulting properties of the oligomer. The effect
of intramolecular hydrogen bonds and aggregation were studied for their ability to
lead to interesting conformations of oligoureas. The oligomers contained
hydrogen bond donors and acceptors, as well as a significant volume of
hydrophobic matter. We hope that aggregation and self-condensation of the
monomer units will lead to cooperative effects in these large oligomers, leading
to stronger hydrogen bond interactions and stable repeating conformations.
1.2 Introduction
Guanidinobenzimidazoles 1a-c, g and 2-amino-1carboxamidinylbenzimidazole 1d-f offer a unique opportunity to study the effect
of substitution patterns on the strength of an intramolecular hydrogen bond. The
hydrogen bonds of these structures were analyzed to determine the
conformational control that they exert over conjugated systems capable of
tautomerization. The intramolecular hydrogen bonds in these structures are
found in a general class of 1,3-diamino aromatic structures. A classic example of
this type of hydrogen bond is found in ‘proton sponge’, 2, in its protonated
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form.9,20,21 Crystal structures of protonated 1,8-diaminonaphthalene derivatives
have an N-H-N hydrogen bond length of ~2.65 Å.9 This value is close to the N-HN bond distance in neutral guanidinobenzimidazole in the solid state (crown ether
complex 2.69 Å8, and uncomplexed 2.75 Å35). Isopropyl substituted
guanidinobenzimidazole, 1c and 1g also had similar bond distances of 2.67 Å,
and 2.78 Å (this work). The gas state calculated structure of 1f had a N-H-N bond
distance of 2.80 Å despite some steric issues that prevent a planar molecule. In
the crystal structure of 1d there were no intramolecular hydrogen bonds,
indicating that the hydrogen bond should be weak.
The 1,8-diaminonaphthalene salts have raised questions about the
possibility of low barrier hydrogen bonding. The major difference between these
six-centered internal hydrogen bond acceptor pairs and the models studied in
this work are the charge and the symmetry of the intramolecular hydrogen bond.
Protonation of 2 reduces the strain caused by the steric crowding and the
repulsion between the lone pairs of the nitrogen atoms, and lowers the energy
required for protonation. The proton involved in the hydrogen bond in 2 is
constrained to point at the hydrogen bond-acceptor nitrogen atom, strengthening
the intramolecular hydrogen bond.34
Conjugated systems can increase hydrogen bond strength. When a
system, like 1, significantly perturbs the stability of an intramolecular hydrogen
bond, the effect is referred to as resonance-assisted hydrogen
bonding.16,17,36,37 Our work indicated that the stability of the intramolecular
hydrogen bond in model structures 1a-f was intimately tied to the local structure.
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This work compared the stability of the hydrogen bond in 1b-c,g with analogous
interactions in 1d-f. The solvent effect was also considered. The hydrogen bond
in 1a-c,g had limited control of the dynamics of the structure, but slow proton
exchange, and limited conformational mobility were required to explain how the
hydrogen bond in 1d-f appeared to contribute significantly to the dynamics of the
structure.
1.2.1 The impact of hydrogen bonds on the conformation of organic
molecules
Intramolecular hydrogen bonds are implicated in the control of the
conformation of many biological molecules and are said to contribute to the
interactions necessary for efficient molecular recognition. 11,12,25,32 Hydrogen
bonds are a primary source of conformational stability in proteins and DNA,
GHFUHDVLQJWKHPRELOLW\RIKHOLFHV-VKHHWVDQG-turns. In DNA, the double
helix is held together by multiple hydrogen bonds in a conjugated system. In
these systems, each hydrogen bond has an estimated strength of 6-7 kcal/mol
from mass spectrometric experiments.18 All together, these interactions bind the
strands together, and provide a basis for the genetic code. However, each
hydrogen bond individually is weak enough for the changes in state necessary
for the repair and packaging processes required by the biological mechanism.
The strength of an isolated hydrogen bond interaction is generally
between 2.1 and 5.8 kcal/mol,16 and is primarily an electrostatic interaction. The
length of this type of hydrogen bond is between 2.65 Å and 2.84 Å from
heteroatom to heteroatom.15,16 X-ray diffraction analysis of derivatives of 2-
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aminobenzimidazole analyzed in this work uncovered hydrogen bonds in this
range of N–H–N distances. This indicates that 1b,c,g possess mid-range, text
book hydrogen bonds that may say something in general about the impact of
hydrogen bonds on conformational stability. These derivatives were compared to
another derivative that displayed similar dynamics, but was stericly inhibited from
forming short hydrogen bonds. Hydrogen bonds that are longer than 2.84 Å are
usually considered weak, and those that are shorter than 2.65 Å are considered
strong. The crystal structure of 1d indicated that 1d-f might not necessarily have
a strong hydrogen bond despite dynamics that indicate that exchange is slow
between the two alkyl groups R3 and R4.
One of the reasons to study six-centered intramolecular hydrogen bonds
is their putative usefulness in stabilizing designed conformations of molecules for
the purpose of molecular recognition and drug design. The conformation instead
of just the structure is often the target in the design of pharmacophores. This
requires the ability to direct the molecular conformation, a task in which hydrogen
bonds should prove useful. In pursuit of this task, five- and six-centered
intramolecular hydrogen bonds can be used to induce greater stability in
dendrimers with the goal of developing dendrimers that fold into stable ordered
conformations.23 Circular dichroism (CD) shows that the 2-aminobenzamide
connectors, highlighted in bold in the figure below, increased the structural
stability of this dendrimer. Without these connectors, the degree of helicity in the
dendron was highly solvent dependant.22,33 In addition, without the connector,
changing to a polar solvent caused a decrease in the CD absorption of the
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dendrimers. Addition of the connector in each generation of the dendrimer
caused increased helical order with each new generation.23 This comes despite
the fact that the chromophore is concentrated at the periphery of the dendron.
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Figure 1.2 Conformational control of dendron packing with five and sixcentered intramolecular hydrogen bonds in a second-generation dendron.
The conformation of the above dendron is directed by intramolecular
hydrogen bonds.22 If the internal structure of the dendron was stabilized in a
helical form this would correlate to increased peripheral helicity. A 2aminobenzamide turn unit highlighted in bold in the figure above was used to link
each generational shell, and formed a stable six-centered intramolecular
hydrogen bond between adjacent amides linked through this subunit. The linker
induces a turn in the dendron that folds the outer dendritic shells.22 The
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conformational direction of the intramolecular hydrogen bond is assisted by the
stiffness of the three bonds between the hydrogen bond donor and acceptor.
This allows for a finite amount of conformers, and an enhancement of the
conformational direction of the intramolecular hydrogen bond results.
A similar result comes from 2; in it, the cleavage of the hydrogen bond is
slow on the NMR time scale.20 This proton sponge is protonated and
deprotonated slowly and equilibration of the (d,l)[2H+] to the thermodynamic
mixture of meso and racemic forms takes about 10 min.9 The free energy barrier
to rotation does not decrease with increasing solvent polarity, and the strain
energy, which is relieved upon protonation of the tetramethyl proton sponge
analogous to 2, has been calculated at 35 kJ/mol.9 From these observations, it
appears that these six-centered intramolecular hydrogen bonds are useful for
controlling conformation in structures in which conformational options are limited.
1.2.2 The intramolecular hydrogen bond
Measurement of the distance between heteroatoms is quite useful in
identifying strong hydrogen bonds inside proteins and other intramolecular
hydrogen bonds. The parameter, dAB is the distance between two electronegative
atoms, A and B, in the species A—H---B. As dAB decreases, the A-H bond length
increases. In 1,3-diketones at a dOO of 2.4 Å,32 the proton is equidistant from
both oxygen atoms, and the O-H distance decreases in length as dOO increases
(See Figure 1.3). The increased symmetry and decreased d OO reduces the
barrier to hydrogen atom exchange between the two oxygen atoms to the point
where the barrier can become less than the zero point vibrational energy.32
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Figure 1.3 Normal hydrogen bonds versus the resonance assisted
hydrogen bond showing a lowering of the energy barrier to proton
exchange from resonance considerations.
This type of hydrogen bond is called a ‘low barrier hydrogen bond’ and is
sometimes identified by a distinctive change in the 1H NMR chemical shift of the
protons of interest. The chemical shift of some of the NH protons in 1c and 1g
moved downfield as the temperature of the sample was reduced. The large
downfield chemical shift is not seen in 1d. This is the derivative with greater
conformational control, but no apparent hydrogen bond in crystal structure
evidence. 1c and 1g are the chemicals in which a short intramolecular hydrogen
bond was found in the crystal structure. In 1d a short intramolecular hydrogen
bond was not found in the crystal structure. This effect has been used to identify
low barrier hydrogen bonds, but other evidence contradicts this conclusion. In
one piece of evidence the downfield proton has a similar chemical shift at room
10

temperature as an imidazole proton, and this exists in the 1c, and 1g, not in 1d.
In a low barrier hydrogen bond, the proton oscillates equally between the two
heteroatoms, and as the temperature is reduced, the proton spends more time
exactly between the two heteroatoms. This effect decreases the electronic
shielding of the hydrogen nucleus, which results in a downfield shift.
Intramolecular hydrogen bonds show a similar effect, but the magnitude is
generally decreased compared to low-barrier hydrogen bonds. Thus, smaller
downfield shifts are used to identify intramolecular hydrogen bonds. 19 In one
system, VT-NMR and VT-IR were used to detect and identify free and
intramolecularly bound amide NH.19 The intramolecular hydrogen bond seen in
1c, and 1g however had little effect upon the dynamics of the guanidine moiety
under protic conditions. Under conditions with no protic solvent and limited
amounts of an analyte, conformational control increased.
1.2.3 Intramolecular resonance assisted hydrogen bonds
Intramolecular hydrogen bonds connected by a series of conjugated
bonds can be much stronger than the normal hydrogen bond with the same two
atoms not electronically connected by a π-system. This hydrogen bond is
typically called a ‘resonance assisted hydrogen bond.’ Hydrogen bonds can
affect changes in covalent bond order. Figure 1.3 shows 4, which is a typical
resonance assisted hydrogen bond. Compound 4 is connected by a series of
conjugated bonds and when compared to 3, has the stronger hydrogen bond.
The carbonyl in 4 is lengthened, and in fact, this trend is general. The smaller the
O-O distance, the longer the carbonyl stretching frequency.15,16
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In this part of the thesis we probe the differences in stability between two
types of six-centered intramolecular hydrogen bonds both possessing πconjugated N1-C2-C3-C4-N5-H6 connectivity 1a-c,g and 1d-f. We found that the
relationship between the two different types of six-centered intramolecular
hydrogen bonds was tentative and differences could not be directly compared. In
1a-c,g proton exchange obscured the energy of the intramolecular hydrogen
bond, but evidence does suggest that the hydrogen bond and the hydrogen atom
exchange that accompanies it is adds more electron density between C2 and
N10 and less between C11 and N10.
1.3 Determination of the conformational stability of a six-centered aromatic
system with an intramolecular hydrogen bond.
Six-centered aromatic structures with an intramolecular hydrogen bond
have proven to be useful in the design of conformationally stable molecules. This
functionality, seen in structure 1a-g, was investigated experimentally though an
analysis of the dynamics of these molecules. The hydrogen bond in 1a should be
stable in solution, but the chemical literature gives conflicting evidence regarding
the stability of the intramolecular hydrogen bond of guanidinobenzimidazole. The
crystal structures of 1a show an N1-N12 distance of 2.75 Å,35 and show the
molecule to be planar.1 This implies that the hydrogen bond can obtain optimal
conformation.16,17 However, in solution there is little evidence for a strong
intramolecular hydrogen bond or for a static planar structure.1,7,35,38 Solution
state 15N, 13C and 1H NMR studies indicate a weak or non-existent intramolecular
hydrogen bond for 1a because the 15N12/ 15N13 exchange is rapid and
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accelerated by protic solvents.1,5,10 The exchange of 15N1/ 15N3 in 1a at the
imidazole ring correlates with protic exchange, but is not mechanistically related
to guanidino 15N12/ 15N13 exchange. In 1a dissolved in CD3OD, both processes
are fast on the NMR time scale; however, DMSO d6 suspends 15N1/ 15N3
exchange and allows 15N12/ 15N13 exchange. This behavior indicates that proton
exchange is a bimolecular process in the absence of protic polar species. In
DMSOd6 intermolecular proton exchange is suspended by impeding the
aggregation of 1a. Our studies of the guanidinobenzimidazole derivatives also
indicate that exchange of the benzo hydrogen atoms is more strongly related to
proton exchange than exchange of the alkyl groups attached to the guanidine
terminus.
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Figure 1.4 Crystal structure of 1c

Figure 1.5 crystal structure of 1g
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Figure 1.6 Crystal structure of 1d
Figures 1.4 and 1.5 show that the guanidinobenzimidazole derivatives
1c,g are planar in the solid state, while Figure 1.6 shows that 1d was not. The
intermolecular hydrogen bonds in the crystal structure of 1c did not interfere with
the planarity of the molecule as seemed to be the case in 1d Figure 1.6.
Molecules of 1c stacked in antiparallel fashion hydrogen bonded with each other
to form a T-shaped aggregate. This interaction could have been of the cation-π or
proton-π type that have been recently investigated.14,28,31,40
In contrast to the molecule 1c, in one molecule of 1d N3 and N10
hydrogen bonded with a symmetry-unrelated molecule of 1d at N12 (16). In the
crystal structure determination of 1d the dihedral angle of axis V (see Figure 1.7)
was close to 90° with 4 different intramolecular hydrogen bonds with other
15

molecules of 1d, and one with the carbonyl oxygen of a molecule of ethyl
acetate. This occurs despite the fact that esters tend to be very poor hydrogen
bond acceptors. In solution, the amount of tight intermolecular hydrogen bonds
should have been reduced and the packing forces of the crystal eliminated. In
fact, the two isopropyl methine protons were distinctly different in the proton
spectra. This may be attributed to an intramolecular hydrogen bond, however in
contrast to what is observed for the 1a-c,g, exchange rates were unaffected by
the polarity and proton availability of the solvent. A gas phase calculation
minimized to a dihedral angle of 36-42° for rotation about axis V for the TT
conformer of 1d shown in Figure 1.9. This calculation was run with Gaussian at
b3lyp/631G* theory level. The structure was optimized at this theory level using
the standard minimization protocol for all possible conformers described in the
text under Figure 1.10.
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Figure 1.7 Axes of rotation observed to exchange protons in 1H NMR
This work studied the impact of small changes in the substitution pattern
of a conjugated heteroaromatic system and an intramolecular hydrogen bond in
guanidinobenzimidazole on the structure and dynamics of the molecule. The
barriers and rates were determined by monitoring the exchange of a set of alkyl
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protons or a set of benzo protons on the derivative of 1. For derivatives 1b,c the
rate of exchange by rotation was determined for two bonds, N13-C11 and N10C2 (axis Y and Z in Figure 1.7) using VT-H1NMR for acquisition of kinetic data.
For derivatives 1g, the rate of exchange by rotation was determined for two
bonds, N10-C11 and N10-C2 (axis X and Z in Figure 1.7) using VT-H1NMR for
acquisition of kinetic data. Exchange was assumed to occur around axis Y but
the rates were too fast or the chemical shifts too similar for interpretation of the
exchange rates. Exchange rates were also determined for the rotation around
N13-C11 and N1-C11 (axis W, V in Figure 1.7) for 1d,e. In 1a-c, rotation around
axis X and Z broke the intramolecular hydrogen bond, but rotation around axis Y
did not. Rotation around axis X was not favored because this rotation would have
resulted in a sterically strained structure instead of a hydrogen-bonded structure.
Only rotation around Y and Z were observed. In 1d,e rotation about axis U and V
broke the hydrogen bond, and W did not. However, proton exchange was
required for the exchange to occur. The molecule only registered one pKa at
about pH 7 and none at a low pH. Proton exchange may be very slow at the
carboxamidine nitrogen atoms in this situation. Again, two rotations were
observed W and V. Rotation around the axis U by itself would work against a
double bond. To get to a ground state from this conformation would require
another rotation around axis V. With a proton exchange, rotation U combined
with V would be the same as a simple, single rotation around W. This issue is
discussed in detail in the text under Figure 1.9.

17

The CN double bond in 1d,e appeared to direct the conformation of alkyl
groups. One alkyl group was held over the benzo part of the heterocycle, and
the other near the amine. The hydrogen bond could not be strong due to the
significant steric hindrance that prevented planarity in 1d. With 1b,c there were
more degrees of rotational freedom for the six-centered intramolecular hydrogen
bond than for 1d,e. The molecule 1b,c appeared to rotate about axis Z with
almost no hindrance from the intramolecular hydrogen bond under protic
conditions.
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Table 1.1 Rate of exchange for the derivative at the indicated axis in the
indicated solvent.
Conc. Of protic

Solvent
CD3OD

CDCl3

Bond
1b Y

1c Z

material in CDCl3
sample per 750 ul

72.5 Hz (213 K)

81.1 Hz (213 K)

*

8 mg 1b

16.3(218 K)

8 mg 1c

60.2 (243 K)

8mg 1c

*

20 mg 1c

1c Y

962.8 Hz (225 K)

1332.9 Hz (228K)

20 mg 1c

1c (N13FiPr)

967.5 Hz (214 K)

*

20 mg 1c

1d V

722 Hz (328 K)

406.2 Hz (305K)

8 mg 1d

1d W

132.8 Hz (250 K)

100.0 Hz (257K)

8 mg 1d

1e V

156.2 Hz (290 K)

123.1 Hz (296K)

8 mg 1e

1e W

14.9 Hz (230 K)

ND

8 mg 1e

1g X

116 Hz (223 K)

283 (263 K)

8 mg 1g

1g Z

158 Hz (223 K)

7 Hz (263 K)

8 mg 1g

1.3.1 Determination of the energy barriers for guanidinobenzimidazole
derivatives by VT-1H-NMR.
The above rates of exchange in table 1.1 were used to determine the
barriers to exchange for all the derivatives of 2-aminobenzimidazole. Exchange
rates were determined from the equation k=ûAB/21/2 where ûAB is the difference
19

in chemical shift of the resonances undergoing chemical exchange. Limiting
values for ûAB in many cases were determined by plotting the difference in
chemical shift over a range of temperatures. Substituting the exchange rate, k,
into the Eyring equation, k=(kBT/h)exp(-ûG‡/RT), allows for the determination of
ûG‡. The error in the rate measurement was about 6-9% as given by gNMR™ for
the accuracy of its full line shape analysis. The concentration of the analyte is
given, because the rates are at least partly dependant upon proton availability.
For cases in which the two peaks did not coalesce, and for double checks
of the accuracy of the coalescence method, the rate of exchange was found by
analyzing the shape of the peak with the program gNMR™. The program
estimated the rate of exchange required to simulate a peak with the required
peak width and position, from the low temperature chemical shifts and from
imported real data points of the peaks of interest into gNMR™. A limited amount
of exchange information could be processed from the current system. With the
systems 1d,e the simulations program was not set up to handle all the protons
and the multiple conformers for determination of rotation around axis V. The
presence of multiple conformations was simulated with line broadening which
was consistent over multiple temperatures.
1c also had multiple conformers at low temperatures in CD3OD and
CDCl3. These conformers were well resolved in methanol but not in chloroform,
which has a smaller working range of temperatures for VT-NMR. As a result, only
the methanol set was resolved into its component rates. 1g had the potential for
having multiple conformers in low temperature solution. The average position of
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the two isopropyl methine resonance peaks in chloroform and in methanol shifted
slightly as the temperature was lowered. This may indicate an unequal
population of two sets of conformers. To compensate for this, and to reduce error
in the calculation, the chemical shift of the two peaks was set as a variable and
simulated in gNMR™.
To determine the exchange rate of two inequivalent isopropyl methine
protons, they were coupled with six equivalent protons, and the two methine
protons were exchanged to match the peak shape of the spectrum, thus
simulating the coalescence of two methine protons. The peaks for the part of the
spectrum of interest were imported into the program and the program matched
the shape and the size of the peaks by automatically calculating a probable
exchange rate to change the size and shape of the peaks, then recalculating the
exchange from the difference in the calculated and the experimental spectra.
Solvent and other extraneous peaks are truncated to avoid confusing the
program
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Table 1.2 Experimental energy barriers for the derivative at the indicated
axis in the indicated solvent.
¨*‡rotation (kcal/mol)
Conc. Of protic

Solvent
CD3OD

Axis

CDCl3

material in CDCl3
sample per 750 ul

1b Y

10.5 (213K)

*

8 mg 1b

Low exchange catalyst

1c Z

10.2 (213K)

11.4 (218 K)

8 mg 1c

12.1 (243 K)

8mg 1c

High exchange catalyst
*

20 mg 1c

1c Y

10.5 (225K)

<10.1 (228K)

20 mg 1c

1c (N13FiPr)

9.5 (214K)

*

20 mg 1c

1d V

14.4 (298K)

14.2 (305K)

8 mg 1d

1d W

12.1 (250K)

12.6 (257K)

8 mg 1d

1e V

14.0 (290K)

14.5 (295K)

8 mg 1e

1e W

12.1 (230K)

*

8 mg 1e

1g X

10.8 (223K)

12.4 (263 K)

8 mg 1g

1g Z

10.7 (223K)

14.3 (263 K)

8 mg 1g

In the table above the symbol * indicates that the NMR peaks did not
separate at temperatures at which CDCl3 is in the liquid state, or there was not
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enough information to determine the rate of exchange. The pKa values for 1a-d
were 7.2, 7.3, 8.2, and 7.4, respectively. The pKa of 1e was not determined due
to low aqueous solubility.
1.4 Mechanism of exchange
The X-ray structures of 1a,c,d, and g show a material with nitrogen atoms
that have a flat trigonal pyramidal geometry. This indicates that N12 and N13
(numbering from Figure 1.1) have significant p character. Furthermore, the
mechanism of geometrical isomerization of C=N apparently switches from
inversion to rotation as the CN bond order decreases.2,30 Three resonance
structures distribute electrons in guanidine, so that the three CN bonds have
bond orders greater than one and less than two.
1.4.1 Inversion or rotation
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Figure 1.8 Mechanisms of exchange for substituents on guanidine.
Inversion (3a to 3b to 3d) (see Figure 1.8) has been promoted as the best
mechanism for exchange of substituents on monosubstituted nitrogen atoms of
guanidine, whereas rotation (3a to 3c to 3d) is the only mechanism for
disubstituted nitrogen atoms in neutral guanidine and in all guanidinium
species.24 In one case, the barrier to rotation in a guanidine was estimated to be
12 kcal/mol higher than the barrier to inversion!24 This result seems incredible
given that sp2 hybridized nitrogen atoms in charge-neutral 4-nitro-4'23

dimethylaminodiphenyldiazene 4 rotate in polar solvents and invert in apolar
solvents.39 One of two compelling pieces of evidence for inversion in guanidine
derivatives comes from Hammett free energy correlations in which σr stabilizes
the transition state through electron withdrawal.2,24 Other evidence comes from
trends observed in known barriers to inversion and rotation. Steric hindrance
usually impedes rotation and facilitates inversion, and steric strain in neutral
guanidine facilitates exchange of substituents on nitrogen atoms in which
inversion is feasible. When the two disubstituted guanidine nitrogen atoms are
connected with an ethylene linker in a basic guanidine molecule, the barrier to
rotation is decreased by approximately seven kcal/mol. 4,30
The mechanism of geometrical isomerization of C=N apparently switches
from inversion to rotation as the CN bond order decreases.2,30 This correlates
well with a mechanism of heterolytic or a homolytic cleavage of the pi-bond as in
the transformation of 3a to 3b in Figure 1.8. The isomerization barrier of phenylcarbonimidic acid dimethyl ester, (MeO)2CNPh, 14.4 kcal/mol, was found to be
higher than that of phenyl dithiocarbimidoic acid dimethyl ester, (MeS)2CNPh,
with a barrier of 13.8 kcal/mol.30 Therefore, greater resonance stabilization leads
to a lowered barrier to rotation around the CN double bond.
General sentiment in the literature is that disubstituted amines in
guanidine bases rotate.3,4,30 The above mechanisms only require rotation at
disubstituted amines. The exception to this rule is the rotation along axis Z in
derivatives 1b,c, and along axis X and Z in 1g. Calculated barriers for this
rotation are similar to the experimentally determined value for the barrier to
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exchange. Again, 1b,c are tautomerizible compounds and proton exchange can
produce the high-energy tautomer 15. The dynamics of 15, described below,
demonstrate another believable mechanism for the rotation around axis Z.
Dynamic studies of 1a-g also indicated that rotation and not inversion was
the best (most simple) explanation for the exchange of nuclei. On the N,Nderivatives 1b,c exchange was observed between alkyl groups on N13, and
between protons on benzo carbons C4, C7 and between C5,C6. Rotation of axes
Y and Z made the observed exchange match the mechanism of exchange. With
the intramolecular hydrogen bond intact in the ground state, inversion at N10
makes a high-energy structure, which must then rotate to get to a lower energy
structure or invert to return to the original configuration. Calculations revealed in
the ground state structure of 1b,c that N10-C2 had a bond order closer to 1 than
to 2. A lower bond order generally means rotation and not inversion.30
There are two possible explanations for the dynamics of 1d,e. In one, the
hydrogen bond influences the dynamics of the molecule differentiating the two
alkyl groups on the carboxamidine functional group. In this scenario, proton
exchange is fast, and rotation is slow along axis V. Therefore, the steric
hindrance should also prevent the carboxamidine group from aligning parallel to
the benzimidazole. However, this system did not act like the other systems 1c,g,
the system was not affected by any increase in a weak proton exchange catalyst
like methanol. In the other scenario, alkyl groups are not differentiated by the
hydrogen bond, but by the stable imine. In this scenario, rotation is slow along
axes U and W, and proton exchange is slow. The carboxamidine NH may be
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much more stable than the imidazole or guanidine NH. This is the simplest
explanation and is explained below.
1d-f CT conformer
N

H

N

H

N

R

4

N
H

N
R3

rotation at W

H

N
R4

H

N

H

N

N

N
N

TT' conformer

TT conformer

H

Proton Exchange
+ rotation at V

N
R3

N
H N
R3

H
N
R4

Figure 1.9 Observed species in solution for derivatives 1d,e
The dynamic behavior of 1d,e could be explained by the structures in
Figure 1.9. There were two possible conformers, the CT and the TT conformer,
and both were detected in solution at low temperatures. The CT conformer has
one isopropyl group cis and one trans to the benzimidazole. The TT conformer
has both groups trans to the benzimidazole. The exchange at axis V was a high
temperature phenomenon and at axis W, a low temperature phenomenon. The
proton the nitrogen atom adjacent to R4 was a controlling factor in all
conformations of the molecule. The presence of this proton in 1d-e broke the
symmetry across the plane containing the 2-aminobenzimidazole moiety in 1d-e.
This rendered the two R groups in the TT conformer diastereotopic in
magnetically distinct conformational space. The R groups in the CT conformer
are of course diastereotopic regardless. In the ca. 1: 1 mixture of TT to CT two
pairs of iPr methine signals are visible at low temperature. If proton exchange
was very slow on the carboxamidine moiety then the presence or absence of the
proton exchange is important for the exchange phenomena that occur between
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R3 and R4. Steric interactions between the benzo CH and the carboxamidine NH
or R4 keep R3 and R4 diastereotopic. The rotation of the carboxamidine group
along axis V of the TT conformer perpendicular to the benzimidazole makes the
two R groups equivalent assuming fast proton exchange. Dynamic 1H NMR
supported these conclusions.
1.4.2 Conjecture regarding the rotational transition state of 1b-c
A set of tautomers was investigated computationally for 1b,d, and f to
determine which was the lowest in energy and had the lowest barrier to rotation.
The barriers to rotation could be determined experimentally for a set of
structures, and ab initio calculations determined the barrier for individual
tautomers. Barriers to rotation could be experimentally determined by monitoring
the slow exchange of a set of protons in the 1H-NMR, and calculated ab initio
with a modeling program that optimized the structure at 6-31G* theory level.
Calculations were run by the method described below, to determine the rotational
transition state. VT-NMR experiments, as described section 1.5 in were used to
experimentally determine the barriers to rotation. The comparison of the barriers
determined by experimental and ab initio methods were used to generate
theories on the strength of the intramolecular hydrogen bond and the
mechanisms of exchange in the 1H-NMR.
1.4.3 Ab-initio studies of energy barriers to rotation about C-N partial
double bonds
Using the Gaussian98 program13 for molecular modeling a barrier to
rotation was determined for N,N-dimethyl-N’-2-benzimidazoyl at two different
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bonds. First the ground state for the molecules was found by an optimization of
the molecule starting from a planar state and optimizing at the B3LYP/6-31G*
level of theory. For this conformation, the energy was calculated at the MP2/6311++(2d,2p) level. To determine the barrier to rotation about the Z-axis, the N1C2-N10-C11 dihedral angle was set and frozen at 90º and then optimized, at the
B3LYP/6-31G* level of theory, with that dihedral angle still frozen. The energy for
this conformation was then calculated at the MP2/6-311++(2d,2p) level;
subtracted from the calculation of the energy of the planar structure also
calculated at this theory level. This procedure was repeated for the C2-N10-C11N12 dihedral angle for 1b.
The intramolecular hydrogen bond appears to still affect the molecule
even with the dihedral angle of C2-N10-C11-N12 set to 90º out of the plane. N1N12 bond distance for 1b was 3.33 Å versus 2.70 Å when the dihedral angle is
not constrained. N1-N12 bond distance was 2.67 Å in the crystal structure for 1c.
Both of these distances are within the definition of a hydrogen bond.
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Table 1.3 Energy (kcal/mol) of tautomers vs. a ground state tautomer from

Ab initio modeled structures.
Bond
Compound
13b or 1b

C2í110
Flat
0.0

C2í1
Twisted
9.0

N10í&
Twisted
17.1

15b

13.9

14.2

No calculation

1f

0.0

9.4

18.7
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Figure 1.10. Mechanisms for exchange in N,N-substituted
guanidinobenzimidazole
In table 1.3 and 1.4 all energies are referenced to the ground state
tautomer 1b and 1f, which are the N,N-dimethyl derivative, and N,N’-dimethyl
derivatives. Calculations were done at MP2/6311G++(2d, 2p) in the gas phase.
Subtract the flat ground state energies from the twisted transition state energies
to calculate particular energy barriers. Subtract the energies of the tautomers to
appreciate which tautomer may likely dominate the equilibrium mixture. Bear in
mind that the observations were made in solution, not the gas phase.
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Table 1.4 Energies calculated with simulated solvent PCM method
Bond

C2í1IODW

Compound
1b or 13b

û+RIVROYDWLRQ

0

-12.66

15b

12.8

-15.58

1f

0.0

-12.75

Calculated energies (kcal/mol) of tautomers in Figure 1.10. The lowest
energy tautomer in each substitution pattern was assigned zero energy; the
energies of the other tautomers were referenced to these. Calculations were
done at the 6í* WKHRU\OHYHOXVLQJthe Polarized Continuum (overlapping
spheres) model (PCM) with water dielectric. The cavity was built up by putting a
sphere around each solute atom, using UAHF radii when available and UFF radii
otherwise with a scaling factor of 1.0 for protic hydrogen atoms and 1.2 for all
other atoms. For a complete discussion of these methods see:
http://www.gaussian.com/00000474.htm.
The exchange between tautomers 13-17, shown in Figure 1.10, represent
the two observed exchange mechanisms for N,N-dialkylated
guanidinobenzimidazoles, and the tautomeric pair that most likely undergoes the
rotational exchange. For calculations sake tautomers 13b, 15b, and 16b were
calculated using R=methyl for tautomers of 1b to reduce calculation time and
memory requirements. Ab initio calculations show that tautomer 15b should have
facile rotation around axis Z, and the intramolecular hydrogen bond in 15b should
be very weak. Calculations showed that rotation along axis Z only raises the
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energy of 15b by 0.3 kcal/mol. Tautomers 13b, 14b were lower in energy in the
gas phase than 15,16 by 10.0 and 13.9 kcal/mol, respectively, but conversion of
15b to 16b is energetically downhill by 3.9 kcal/mol. The calculated barrier to
rotation along axis Z for 13b was 9.0 kcal/mol and was within 1.2 kcal/mol of the
experimental value of 10.5 kcal/mol. In solution, 15b maybe accessible, but
rotation of axis Z from 13b seems to be the best explanation of the dynamics of
the C2-N10 bond.
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Figure 1.11 Is proton exchange occurring in the crystal structure?
The crystal for 1c showed a feature in the difference maps of the 1d
crystal that indicated possible proton exchange along the intramolecular
hydrogen bond in the crystal structure. The feature was in the right position to
indicate proton exchange was occurring. If proton exchange does occur there
would be extra electron density on the N10-C2 bond. Figure 1.11 shows the
electronic structure that explains the effects of proton exchange on the rotation at
axis Z. A normal proton exchange can occur under the conditions of bond
vibration of the intramolecular hydrogen bond. Proton exchange along the
intramolecular hydrogen bond of the low energy tautomer 1b would generate
structure 24. This vibration should be possible even under the tight packing
conditions of a solid crystal because motion along the hydrogen bond trajectory
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does not produce much motion in the entire molecule. In solution, this tautomer
was transient and did not appear to have any impact on the dynamics of the
molecule.
Most measurements were taken in the presence of fast proton exchange
using CD3OD. Running the experiments at low dilutions raised the barriers for 1d
by 1 to 2 kcal/mol for the benzo protons. 1g had a greater change in its barrier to
exchange. The change from protic to aprotic conditions increased the barrier to
exchange for the alkyl groups R5, R2 by two kcal/mol to 12 kcal/mol and the
benzo protons by four kcal/mol to 14 kcal/mol.
CT and TT conformers of 1f were analyzed using an ab initio calculation;
methodology was the same as for the above conformers. Calculations showed
the CT to be 1.3 kcal/mol lower in energy than the TT conformer. Both
conformers of 1f were seen in solution with the ratio changing with different
solvents. TT was preferred in methanol, and CT was preferred in chloroform.
1.5 VT Data and analysis
1.5.1 Solvent dependant conformational preference of 1d
1

H-NMR spectra were taken at low temperatures to identify the ground

state conformation, to investigate solvent sensitivity, and to explore the
differences between different substitution patterns of 2-aminobenzimidazole.
Solvent had an obvious influence on some of the conformers of 1d. The solvent
affected changes in the conformation of the isopropyl groups, when the solvent
was changed from CD3OD to CDCl3. The TT conformation was preferred over
the CT conformation in CD3OD, and in CDCl3 a less sterically hindered CT

32

conformer was preferred. Spectrum C, Figure 1.13, taken at -50 Û&LQ&'3OD
shows the CT conformer was slightly favored over the TT conformer. Apolar
solvents like CDCl3 switched the equilibrium to favor the CT conformer over the
TT conformer (see Figure 1.11 spectrum b); compare the methine signals of the

iPr groups at 4.2-3.0 δ in spectrum b in Figure 1.12 (CDCl3) to those in spectrum
c in Figure 1.13. Conformers CT and TT were assigned by NOE. At -50 °C in
MeODd4, TT and CT produced separate 1H NMR signals (1.3: 1.0 ratio, TT: CT).
A NOESY experiment at -70 °C (see appendix) confirmed the proximity of the
two iPr substituents in TT. The two most intense iPr methine protons were
assigned to TT because these correlated with two methyl signals in the NOESY
experiment. The other two methine iPr signals shared cross peaks with one
methyl signal. Cross peaks from chemical exchange between the two methine
protons from the major and the minor rotamer appeared in the NOESY spectrum.
The low-temperature NOESY spectrum is available in the appendix.
1.5.2 Variable temperature 1H NMR of 1d in CDCl3
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Figure 1.12. Stacked spectra showing the dynamic exchange in 1d in CDCl3.
Stacked spectra in Figure 1.11, showed the dynamic exchange in 1d in
CDCl3 as the temperature was decreased. The inset at 35 °C (spectrum a)
clearly showed the first order pattern in the benzo protons. A single benzo proton
was broadened by the presence of the two different conformers. The signals from
the isopropyl groups were broad features at 35 °C, but cooling to -55 °C
(spectrum b) suspended the exchange in the methyl and methine protons on the
NMR timescale. There was a broad protic signal riding on the downfield edge of
the most downfield methine signal at ~4.1 δ. The protic peak at 6.5 δ was
assigned to the intramolecular hydrogen bond.
In 1c,g the exchange rate of exchangeable benzo protons increased as a
proton exchange catalyst was added in aprotic solvents like CDCl3. Addition of
DMSO, an inhibitor of proton exchange led to a downfield shift of the downfield
chemical shifts in 1c. In 1c,g the protic chemical shifts varied as a function of
temperature. In 1d, one of the protic signals (~2H, δ 6.5, -55 °C) changed -11.1
ppb/K in CDCl3, which was approximately 6.3-fold larger than the temperaturedependence of the chemical shift of an upfield protic signal, approximately -1.8
ppb/K (1H, δ 4.05). Temperature-sensitivity of the analogous downfield protic
signals in 1c (1H, δ 10.0, -30 °C) and (2H, δ ~7.3, -30 °C) in CDCl3 was -25
ppb/K for the downfield shift. The upfield protic shift at δ 7.3 was much less
temperature-dependent, but broadened considerably upon cooling. These
protons behaved like the quickly exchanging protic signal of methanold3 in
CD3OD NMR solvent. The upfield protic signal in 1d behaved differently than the
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protic signal in the free solvent and was probably due to the proton in
intramolecular hydrogen bond. Attempts to unambiguously assign these protic
signals failed.
1.5.3 Variable temperature 1H NMR of 1d in CD3OD

Figure 1.13. Stacked spectra showing the dynamic exchange in 1d in
CD3OD.
Stacked spectra showed the dynamic exchange in 1d in CD3OD as the
temperature was decreased. The series from spectrum a at 45 °C to spectrum b
at 0 °C to spectrum c at -55 °C clearly showed two dynamic processes. The first
exchange (spectrum c to b) involved an equilibrium of CT and TT, and the next
exchange (spectrum b to a) involved TT and TT’.
There were four signals, two pairs (1.2: 1.0), for the iPr methine protons of
1c in CD3OD at -50 °C. These appeared to arise from hindered rotation of the iPr
substituents. One of the iPr methine protons in CT and TT was proximal to the
benzimidazole deshielding cone. Probably the deshielding cone of the
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benzimidazole shifted these methine protons downfield by ~ 1 ppm of the other

iPr methine signals. Molecular modeling demonstrated that the interatomic
distance between benzimidazole H4 and the methine proton in CT was ~2.6 Å,
and the analogous distance for TT was ~2.8 Å. Stark changes in magnetic
anisotropy tend to occur above or below the π-system, and the isopropyl groups
were restricted into those areas.
1.5.4 Variable temperature 1H NMR of 1b in CD3OD

Figure 1.14 Stacked spectra showing the dynamic exchange in 1b
Stacked spectra showed the dynamic exchange in 1b in CD3OD as the
temperature was decreased. Two mechanistically unrelated asynchronous
processes exchanged the methyl substituents on the guanidino terminus and the
protons in the benzene ring. From spectrum a to spectrum c the pattern in this
aromatic region changes from AA’BB’ to ABCD, and protons C and D were
broadened but still occurred at the same frequency. Only an upper limit could be
placed on the exchange of the protons in the benzene ring.
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1.5.5 Temperature sensitivity of protic peaks
Exalted temperature-sensitivity in chemical shifts of intramolecular
hydrogen bonds has been reported.37 Chemical shifts of hydrogen bonded
protons occur downfield of analogous protons bound to only one electron donor
because the hydrogen atom partially dissociates from the hydrogen bond donor
atom toward the hydrogen bond acceptor atom. The chemical shift of a proton
involved in a hydrogen bond varies inversely with temperature, if the hydrogen
bond is not a low barrier hydrogen bond.27 The hydrogen in the intramolecular
hydrogen bond in 1d in CDCl3 was found 2.2 ppm downfield of the next most
downfield protic signal in 1d. The slope of the temperature dependence of the
chemical shift for the intramolecular hydrogen bonded proton was -11.1 ppb/K in
CDCl3, which was approximately 6.3-fold larger than the temperature
dependence of the chemical shifts of the other protic signals, approximately -1.8
ppb/K.
1.6 Conclusion.
An intramolecular hydrogen bond was analyzed under conditions of fast
and slow hydrogen atom exchange. We determined that the rate of exchange of
the alkyl groups and benzimidazole protons was influenced by the amount and
rates of hydrogen atom exchange in 1a-g, making an analytical determination of
the hydrogen bond strength difficult. Despite the obvious influence of proton
exchange, the molecule’s dynamics was influenced by the hydrogen bond.
The explanation for the dynamics of guanidinobenzimidazole is a
combination of the effects of a dynamic intramolecular hydrogen bond, hydrogen
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atom exchange, and quite possibly solvent polarity. If guanidinobenzimidazole
and its derivatives had the dynamics that would correspond to a structure
indicated by the tautomer shown in Figure 1.1, then the rotation about axis Y and
Z would be fast, and rotation about axis X would be very slow. However, the
situation is not that simple and the dynamics of the system are more complex.
The effect of a resonance-assisted hydrogen bond (RAHB) was useful in the
explanation of the dynamics of the molecule. Although a direct measurement of
the strength of the intramolecular hydrogen bond was not possible, the dynamics
of the molecule was useful in finding evidence for the presence of the RAHB in
solution. If the RAHB is present, it does not possess the normal strength of a
RAHB. Even under slightly protic conditions of 8 mg / 750 L chloroform, the
exchange is faster for the alkyl groups along axis X than along axis Z. This
implies that bond order has been reduced between C11 and N10 (numbering
from Figure 1.1) and a tautomer like structure 24 in Figure 1.11 is found. In lower
polarity aprotic solvents, this mechanism may be promoted while in polar protic
solvents many tautomers exist with other mechanisms for exchange exist.
Therefore, with redundant mechanisms the potential for exchange increases, as
does the rate of exchange. Our dynamic results are similar to those described
earlier for the dynamics of 15N-NMR spectroscopy of 1a described earlier in
chapter 1.
In 1d,e the exchange of the alkyl groups is remarkably well controlled in
comparison to the conformational control offered by the hypothetical planar
resonance stabilized hydrogen bond did not appear to contribute as much to the
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conformational stability as the hydrogen bond that was not resonance stabilized
or planar. This was a rather remarkable discovery, but the explanation was quite
simple. The carboxamidine functional group had a different pKa than the
guanidine and this led to remarkable dynamics, which appeared unchanged by
differing amounts of a weak proton exchange catalyst. There were at two least
two possible explanations for this behavior. The first rationalization focuses on
the differences between the intramolecular hydrogen bond acceptors in the
derivatives of 1 studied in this thesis. Other arguments were more complex. In
another explanation, the secondary imine nitrogen atom may participate in a
kinetically more stable hydrogen bond than the primary imine nitrogen atom. The
second rationalization focuses on the nature of the hydrogen bond in planar, five
or six centered intramolecular hydrogen bonds. The heteroatoms in these
species may simply be too close for optimal hydrogen bonding. This may be born
out in calculations since the atoms are not all coplanar after optimizing the atomic
positions at a high level of theory. If the bonding pattern positions the
heteroatoms involved in the hydrogen bond too close, the hydrogen bond is
established at the expense of conjugation (non-planar structure) and conjugation
is optimized at the expense of the hydrogen bond. In the absence of the solvent
shell, (x-ray structures, gas-phase calculations) the optimum distance dAB of the
hydrogen bond likely shortens, making the hydrogen bonds give rise to more
planar structures. The third explanation says that the mechanisms and the rates
of exchange are different for the three types of six-centered intramolecular
hydrogen bonds.
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Rotation was found to be the best mechanism for basic guanidines
involved in a six-centered intramolecular hydrogen bond. The barrier to rotation
was measured for two different heterocycles. Barriers to exchange matched well
with the calculated values for the barrier to rotation. These studies provided a
realistic vision of what to expect of intramolecular hydrogen bonds in the control
of de novo designed conformations. If any hydrogen bond will operate to control
conformation, the ones that participate in planar aromatic structures should
contribute the most to conformational control. In general, the six-centered
intramolecular hydrogen bonds studied here were not stable enough to be used
for the design of compounds needing conformational stability.
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Chapter 2
Synthesis of benzimidazole derivatives
Guanidinobenzimidazole has complex chemical reactivity. The guanidine
moiety is difficult to selectively alkylate, and the basicity is more like imidazole
than guanidine. Guanidinobenzimidazole has a pKa of 7.09,1 while that of
benzimidazole is 5.561, and that of guanidine is 14.381. Alkylated derivatives can
be formed in several ways. The optimum method used to form the
guanidinobenzimidazole depends upon the substitution pattern desired. The
most nucleophilic atom on 2-guanidinobenzimidazole is the non-protonated
imidazole nitrogen (N1, numbering system shown in Figure 1.1). The
nucleophilicity of N1 was used to methylate this nitrogen, using a strong
unhindered electrophile like methyl iodide. Other derivatives formed from this
reaction were not isolated due to difficulty in purification.
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Figure 2.1 Synthesis of 2-amino-1-benzimidazole-N,N’-dialkylcarboxamidine
derivatives
Methods to selectively and directly alkylate the terminal nitrogen atoms on
the guanidine moiety, N12, N13 have not been discovered, due to their lower
nucleophilicity. With reactivity again reflective of the nucleophilicity of N1, 1d-f
were synthesized by the condensation of the corresponding N,N’-disubstituted
carbodiimide 22d-f. 22f appears to be particularly labile to solvolysis for N,N’derivative 1f. These derivatives required a moderately bulky substituent for
isolation of a product. Larger alkyl groups appeared to decelerate the solvolysis
of 1d-f. N,N’-Dimethyl derivative 1f was detected in solution, but purification
methods decomposed the chemical. N,N’-Diisopropyl derivative 1d decomposed
over several hours at raised temperatures in protic solvents, but was stable to
silica chromatography. However, because it crystallized pure from non-polar
aprotic solvents, chromatography was not necessary, and the material could be

45

obtained in excellent purity. p-Tolyl derivative 1e was less stable to silica and
small impurities persisted after silica chromatography, presumably due to the
decomposition on the column.
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Figure 2.2 Literature evidence for 2-amino substitution.
Substitution at N1 was unexpected for the reaction of carbodiimides with
2-aminobenzimidazole. Dimethylcyanamide reacted with 2-aminobenzimidazole
when heated in neat dimethylcyanamide at 105 °C at the 2-amino position to
form 1b granted in low yield and impure. Acetylation of the same molecule
proceeded with substitution at N1, but heat caused a rearrangement with
substitution at the 2-amino position.2 With the carboxamidine cation being more
stable than the N-acetyl cation the rearrangement should have been more facile.
2-Amino substitution was expected. In the crystal structure, seen below in Figure
2.3, the product was highly strained with no favorable intramolecular hydrogen
bonding interactions and decreased π-conjugation.
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Figure 2.3 Crystal structure of 2-amino-1-benzimidazole-N,N’diisopropylcarboxamidine
There are at least four different intermolecular hydrogen bonds for every
molecule of 1d. This does not include another hydrogen bond to the carbonyl of a
molecule of ethyl acetate. Planarity and the cohesion of the intramolecular
hydrogen bond between the carboxamidine and the 2-amino protons in 1d is
probably disturbed by the intermolecular hydrogen bonding just described.

Figure 2.4 Crystal structure of 1g.
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Another product is formed when the reaction to make 1d was repeated at
110 °C, refluxing a melt of the two starting materials. This product was identified
as the 2-aminobenzimidazole with the carbodiimide substituted at the 2-amino
position, 1g, shown in figure 2.1. Although the yield was low at around 12% yield,
improvements in the methodology should improve the yield. The crystal structure
for 1g is shown above in Figure 2.4.
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Figure 2.5: Synthesis of N,N-dialkyl guanidinobenzimidazoles
Substitution at only N13 was accomplished with alkyl groups of moderate
to high steric hindrance. N,N-dialkyl-2-guanidinobenzimidazole derivatives 1b,c
were synthesized, as shown in Figure 2.4 above, by the condensation of orthophenylenediamine and an N,N-dialkyl-dicyandiamide. This method has been
shown to be useful in the synthesis of 2-(N-isopropylguanidino)benzimidazole3
and also to make the corresponding dimethyl, isobutyl, piperidino, cyclohexyl,
and morpholino derivatives.4
1b was also synthesized using a similar method with 2aminobenzimidazole and dimethylcyanamide. N,N-Dimethylguanidino-N’-(2benzimidazoyl) 1b was formed by the condensation of 2-aminobenzimidazole
and dimethylcyanamide in low yield. Synthesis of 1c using diisopropylcyanamide
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was unsuccessful. Heat and Lewis acid catalysis resulted in starting material and
decomposed starting material.
Two 2-amino-1-benzimidazole-N,N’-dialkylcarboxamidine derivatives were
synthesized by the condensation of N,N’-dialkylcarbodiimides 22 and 2aminobenzimidazole 23. The synthesis of 1d,e by the reaction of 2aminobenzimidazole with a carbodiimide with alkyl substituents of high steric bulk
(for example, 22d) ran in high yield. For the synthesis of 2-(N,Ndialkylguanidino)benzimidazoles with large alkyl substituents the reaction of
phenylenediamine and N,N-diisopropyldicyandiamide ran in poor yield. For the
synthesis of 8-(N,N-dialkylguanidino)purines, the reaction of 4,5diaminopyrimidine and N,N-isopropyl, t-butyldicyandiamide ran in high yield.
2.1 Synthesis of N,N-dialkylguanidinobenzimidazoles from N,N-dialkyl-N’cyanoguanidines and o-phenylendiamine.
Cyanoguanidines (Dicyandiamides) are typically made from the reaction of
an amine hydrochloride and sodium dicyanamide in refluxing alcohol. The yields
for this reaction are moderate, however decomposition products at the end of the
reaction do not hamper isolation. The only impurities in the product are the
starting materials. The N,N-dialkyl-N’-cyanoguanidine product also called N,Ndialkyldicyandiamide can be purified by extraction into ethyl acetate and
crystallization. A series of N,N-dialkyl-N’-cyanoguanidines were made with the
varying yields shown in Table 2.1.
Table 2.1 Synthesis of N,N-dialkyl-N'-cyanoguanidines
Derivative

Alkyl group
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% yield

26b

R = Methyl

25

26g

R = Ethyl

50

26c

R = isoPropyl

42

26h

R = tertButyl

17

The less sterically hindered N,N-dialkyl-N’-cyanoguanidines were useful in
the synthesis of N-(1H-benzimidazol-2-yl)-N',N'-dialkyl-guanidines. When the

N,N-dialkyl-N’-cyanoguanidines were refluxed in water with 4 equivalents of HCl
and one equivalent of o-phenylenediamine the cyanoguanidines condensed with
the o-phenylenediamine losing ammonium chloride. When N-t-butyl,N-isopropyl-

N’-cyanoguanidine and N,N-dit-butyl-N’-cyanoguanidine were submitted to the
same conditions, no reaction took place. The following derivatives were isolated
in the following yields.
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Table 2.2 Synthesis of N,N-dialkylguanidinobenzimidazoles
Derivative

Alkyl group

% yield

1a

R = Methyl

10-25

1c

R = isoPropyl

10-16

1h

R = tButyl

0

2.2 Synthesis of 2-amino-1-benzimidazole-N,N’-dialkylcarboxamidine from
2-aminobenzimidazole and N,N’-dialkylcarbodiimides or N,N’dialkyluronium chloride salts.
Guanidines can also be synthesized by using carbodiimides and uronium
chloride salts. These reactions were facile and high yielding when the alkyl group
on the carbodiimide had moderate steric bulk. 2-Amino-1-benzimidazole-N,N’diisopropylcarboxamidine (1d) was synthesized using commercially available

N,N’-diisopropylcarbodiimide and 2-aminobenzimidazole. Within 12 h the
reaction had gone to completion by TLC. The crude yield was about 85%. The
crude residue was purified by recrystallization with ethyl acetate. The ethyl
acetate was removed by dissolving in CHCl3, pumping off the residue under high
vacuum, crushing the residue to a powder and again evaporating under high
vacuum.

N,N’-Di-p-tolylcarbodiimide, 22e also reacted with 23 in refluxing THF
overnight, and was crystallized from wet ethyl acetate. A small amount of
hydrolyzed product also resulted from this crystallization, but other methods only
precipitated powder. The yield of this product was good at 76%. The more

51

sterically hindered N,N’-di-tert-butylcarbodiimide did not react with 23 under
refluxing THF, or DMF heated to 60 °C.

N,N’-Dimethylcarbodiimide was synthesized according to a literature
procedure5 for the synthesis of 2-amino-1-benzimidazole-N,N’dimethylcarboxamidine, 1f. N,N’-dimethylthiourea and HgO (dried at 150 °C for 2
h) were stirred at 0 °C to room temperature over 45 min The precipitate was
filtered and concentrated by slow distillation from a bath temperature of 50-55 °C.
This material was used as is and stirred with 2-aminobenzimidazole in CHCl3
overnight under N2. The resulting product was filtered and dried under vacuum.
The 1H NMR in DMSOd6 showed mostly the 2-aminobenzimidazole with a
product that could not be isolated pure.
The N,N’-dimethyluronium chloride was synthesized according to a
literature procedure6 for the synthesis of 1f. N,N’-Dimethylthiourea (107.3 mg,
1.030 mmol) was dissolved in 10 mL dry THF. Triphosgene (328.5 mg, 1.107
mmol) in 5 mL dry THF was added to the thiourea slowly by syringe. The
reactions was stirred for 1 h and refluxed for 3 more. The reaction formed a
precipitate that was dissolved with CHCl3, and again precipitated with THF. The
precipitate was filtered under nitrogen and recrystallized with the CHCl3 and THF
solvent mixture for a total yield of 202.6 mg, 1.901 mmol or 68% yield with
respect to the thiourea. When stirred with 2-aminobenzimidazole the N,N’dimethyluronium chloride reacted in a manner similar to N,N’dimethylcarbodiimide. The reaction was incomplete and the product was
unstable to purification.
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2.3 Synthesis of N,N’-diisopropylguanidinobenzimidazoles

2.3 Synthesis of 1-methyl-2-guanidinobenzimidazole
H2N

H2N
NH2 MeI,
KOtBu

N

NH2

N
N

N
N
H

N

28

1a

Figure 2.6 Alkylation of 1a with methyl iodide
Deprotonation of the imidazole nitrogen N1, in 1a, resulted in Nmethylation of N1 upon treatment with methyliodide. This reaction was
regioselective for alkylations at the imidazole nitrogen. One equivalent of 1a, and
Potassium tert-butoxide and a catalytic amount of 18-crown-6 was dissolved in
THF. An equivalent of methyliodide was added drop-wise to the reaction at 0 °C.
After 5-10 minutes a white precipitate had formed. 1-methyl-2guanadinobenzimidazole, 28, was neutralized and purified by crystallization from
ethyl acetate and hexane (53% isolated yield).
2.4 Synthetic procedures and data
2.4.1 Synthesis of N-(1H-benzoimidazol-2-yl)-N',N'-dimethyl-guanidine (1b)
H 26b

CN
24 NC N
Na+
+

butanol

H N

H

N
NC

1N HCl
Heat 2hrs.

N

+
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NH2
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Figure 2.7 Synthesis of 1b
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Dimethylamine (2.60 mL, 40% aqueous solution) sodium dicyanamide
(1.78 g, 20.0 mmol), and HCl (1.76 mL, 37% aqueous solution) were refluxed for
24 h. This solution was neutralized with Na2CO3 (2M) and extracted into nbutanol. The n-butanol layer was washed with brine and evaporated. The crude

N,N-dimethyldicyandiamide (0.566g, 5.05 mmol, 25% yield) was crystallized from
n-butanol and ethyl acetate. N,N-dimethyldicyandiamide (431 mg, 3.85mmol) and
phenylene diamine (401 mg, 3.71 mmol) and 310 / of conc. HCl was dissolved
in 4.0 mL distilled water. The reaction was refluxed for 6 h then neutralized with
sodium carbonate and water, extracted with ethyl acetate and dried with MgSO4.
After silica gel chromatography (5% TEA in EtOAc) the solution was
concentrated and N-(1H-benzoimidazol-2-yl)-N',N'-dimethyl-guanidine (84.1 mg,
0.381 mmol, 10% yield) was obtained as crystalline material.
H-NMR (300 MHz; CDCl3) δ 7.22 (2H, dd, J=6.1, 3.2 Hz), 6.94 (2H, dd,

1

J=6.0, 3.2 Hz), 3.27 (6H, s) m/z (EI) 259 (M+, 1%), 133 ((M - diisopropyldiimidyl)+,
83%) 13C NMR (75.4 MHz; CDCl3) δ156.702, 156.0, 117.3, 109.7, 33.8. IR(KBr
pellet)2924.9, 2867.5, 1529.9, 1459.3, 1388.6, 1261.2, 1215.2, 1051.5 cm-1 Anal.

Calcd. For C10H13N5 C, 58.80, H, 6.91, N, 34.29 found C, 58.97, H, 6.47, N,
34.07.
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2.4.2 Synthesis of N-(1H-benzoimidazol-2-yl)-N',N'-diisopropyl-guanidine
(1c)
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Figure 2.8 Synthesis of 1c
Sodium dicyanamide (4.34 g, 49.3 mmol) and diisopropylamine (4.85 g,
48.0 mmol) and 4.0 mL concentrated HCl (50 mmol) were refluxed in n-butanol
for 28 h. The solution was washed with distilled water and then 3x with brine
resulting in a pink aqueous phase and a pale clear yellow organic phase. N,Ndiisopropyldicyandiamide (2.33 g, 13.8 mmol, 29%) was crystallized from hot
ethyl acetate. N,N-Diisopropyldicyandiamide (211.7 mg, 1.26 mmol) was refluxed
for 2 h with o-phenylenediamine (140.8 mg, 1.30 mmol) in 2 equiv. HCl(aq) (2.0
mL, 0.66 M). The reaction was worked up with Na2CO3 washed three times with
ether, and then with brine. The solution was concentrated and purified by flash
silica gel chromatography (4: 1, hexane: EtOAc and 5% TEA). The first fraction
(232 mg, 0.894 mmol) 71% crude yield was recrystallized from hexane and
EtOAc.
H NMR (300 MHz; CD3OD) δ 7.99 (dd, 2H, 7.1 Hz, 25.5 Hz), 7.61 (dt, 2H,

1

2.2 Hz, 6.9 Hz), 4.21 (septet, 2H, 6.8 Hz), 1.34 (d, 12H) 13C NMR (75.3 MHz;
CDCl3) δ 156.7, 146.6, 131.3, 129.3, 59.0, 26.5, 22.4 IR(KBr pellet) 3493.6,
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3393.2, 3120.11, 2973.0, 1626.2, 1606.8, 1516.2, 1486.3, 1457.9, 1388.6,
1272.1, 1215.2, 1136.2 cm-1 Anal. Calcd. for C22H21N5 C, 64.84, H, 8.16, N,
27.00 found C, 64.76, H, 8.06, N, 26.92.
2.4.3 Synthesis of 2-amino-1-benzimidazole-N,N’diisopropylcarboxamidine(1d)
22d
N

C

N

CHCl3
2 hrs.

+
H
N

N
NH2
N

NH2
N

23

N

N

H 1d

Figure 2.9 Synthesis of 1d
2-amino-benzimidazole (1.11 g, 8.31 mmol) was dissolved in a solution of
THF with two molar equivalents of N,N'-diisopropylcarbodiimide. Within 12 hours
the 2-amino-benzimidazole was completely used up by TLC. Water was added to
the mixture and the product was extracted into CHCl3. The crude yield was about
85%. The crude residue was purified by recrystallization with ethyl acetate. The
ethyl acetate was removed by the pump freeze thaw method several times.
H NMR (300 MHz; CDCl3, 25 Û& δ 7.40 (d, 1H), 7.27 (broad d, 1H), 7.14,

1

(t, 1H), 7.05 (t, 1H), 5.2-6.0 (broad s, 2H, NH), 3.2-4.2 (broad m, 4H),1.0-1.4
(broad s, 12H); 13C NMR (75.4 MHz; CDCl3) δ 160.6, 153, 141.9, 133.1, 122.6,
116.7, 109.7 (vb), 47.0 (vb), 24.1 (b); IR -3500-3300, 3080, 1640-1700, 1554,
1458, 740; Anal. Calcd. for C14H21N5 C, 64.83, H, 8.16, N, 27.01 found C, 64.51,
H, 8.31, N, 26.55.
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2.4.4 Synthesis of 2-amino-1-benzimidazole-N,N’-ditolylcarboxamidine (1e)
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Figure 2.10 Synthesis of 1e
2-Amino-benzimidazole (299.1 mg, 2.25 mmol) was dissolved in a solution
of 2.5 mL DMF with an excess of N,N’-ditolylcarbodiimide (499.9 mg, 2.25 mmol).
The DMF was evaporated under high vacuum, and the resulting solid was
crystallized from wet ethyl acetate. 1e (607.3 mg, 1.71 mmol) was recovered for
a yield of 76.1%. This material was recrystallized with ethyl acetate and hexane
and ethyl acetate and chloroform. The ethyl acetate was removed by the pump
freeze thaw method several times.
H NMR (300 MHz; CDCl3) δ 7.29 (t, 1H, 8.0 Hz), 7.22 (t, 1H, 8.0 Hz), 7.14

1

(vb, 4H, 9.8 Hz), 7.07 (t, 1H, 9.8 Hz), 7.05 (t, 1H, 6.8 Hz), 6.90 (vb, 2H), 6.66
(vb, 2H) , 2.31 (vb, 3H), 2.17 (vb, 3H), 1.34 (d, 12H) 13C NMR (300 MHz; CDCl3)
δ 172.3, 172.2, 138.7, 132.5, 131.6, 129.3, 125.2, 71.5, 29.4 Anal. Calcd. for
C22H21N5 C, 74.34, H, 5.96, N, 19.7 found C,74.48, H,6.30, N,19.62.
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2.4.4 Synthesis of N-(1H-benzoimidazol-2-yl)-N',N'-diisopropyl-guanidine
(1g)
22e
N

C N
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N
N

Neat,
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H N
N

N
NH2

N
N

23
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Figure 2.11 Synthesis of 1g
2-Amino-benzimidazole (522.8 mg, 3.93 mmol) was stirred with
diisopropyl carbodiimide (450 mg, 4.0 mmol) neat for 48 h at 110 °C. The
reaction was held under a static nitrogen atmosphere with the carbodiimide held
under a condenser. Excess carbodiimide, 22e, was evaporated under high
vacuum, the resulting solid was dissolved in 100 ml ethyl acetate filtered and
addition of a small amount of hexane caused the formation of a suspension
which over time, formed an oily layer on the bottom of the flask. The liquor was
decanted and further addition of hexane caused the crystallization of 1g from
ethyl acetate. 1g (117mg, 0.45 mmol) was recovered for a yield of 12%. This
material was further purified by crystallization with ethyl acetate and hexane. The
crystals were of a yellow brown color and melted at 162°C. X-ray analysis
revealed the form of the chemical shown above in Figure 2.10. Residual ethyl
acetate was removed by dissolving with chloroform and evaporating under high
vacuum, crushing this material into a powder and again evaporating under high
vacuum.
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H NMR (400 MHz; CD3OD) δ7.20 (m, 2H, 3.2 Hz), 6.95 (m, 2H, 3.2 Hz),

1

4.02 (septet, 2H, 6 Hz), 1.23 (d, 12H, 7 Hz) 13C NMR (400 MHz; CD3OD) δ
158.76, 155.15, 137.54, 120.07, 111.91, 42.61, 22.10; IR 3431, 2971, 1598,
1529, 1461, 1402, 1367, 1273, 1176, 736; Anal. Calcd. for C14H21N5 C, 64.83, H,
8.16, N, 27.01 found C, , H, , N, ; EI Mass Spectra m/z 259 (~70%), 244 (20%),
159 (100%), 158 (45%), 134 (20%).
2.4.5 Synthesis of 1-methyl-2-guanadinobenzimidazole (28)
H
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N
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H2 N

N

tBuOK,
NH2 18-crown-6;
MeI

N
28

NH2
H2 N

Figure 2.12 Synthesis of 1-methyl-2-guanadinobenzimidazole (28)
1-Methyl-2-guanadinobenzimidazole, 28 was synthesized from 2guanidino-benzimidazole (1a), with methyl iodide as an electrophile 1.63 g (9.30
mmol) 1a, 1.04 g potassium tert-butoxide (9.27 mmol) and 0.172 g (0.651 mmol)
18-crown-6 was dissolved in 40 mL THF. This solution was chilled to the
temperature of melting ice. Methyl iodide (0.580mL, 9.30mmol) was added drop
wise and the reaction was allowed to rise to room temperature. After 5-10
minutes a white precipitate had formed. The volume of the THF was reduced and
the material was neutralized with 1 M NaHCO3. The organic layer was then
extracted with CH2Cl2 and H2O 3 times. An amount of 0.94 g (5.0 mmol) 1methyl-2-guanadinobenzimidazole product was purified by crystallization from
ethyl acetate and hexane (53% yield). Spectral properties of the product were
identical to those previously reported in the literature.1,7
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Chapter 3
Design, synthesis, and evaluation of an oligomeric
helical receptor
This chapter focuses on the design of a conformational motif for molecular
recognition of anions. Synthetic challenges were encountered in the work so the
experimental progress was limited. However, much of the iterative design hinged
on sound experimental results.
O
H
N

HN

29
Figure 3.1 Oligourea receptor
3.1 Introduction
Hypothetical oligomer 29 should possesses repetitive conformational
motifs capable of switching between inter and intramolecular hydrogen bonding.
Molecular modeling studies showed that these oligomers had a high propensity
to form multiple cooperative hydrogen bonds, and a helix was the most favored
conformation. Furthermore, the helical conformation, should be stabilized relative
to other conformers in the presence of anionic species. A differentially protected
dimer of 29, n=2, showed a very organized pattern of self-aggregation in the solid
state by x-ray diffraction. Using the dimer of 29 and extrapolating to n-mers in
PROHFXODUPHFKDQLFVFDOFXODWLRQVSURYRNHVWKHQRWLRQWKDW-sheet-like
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aggregation will be a low energy conformer of this material. When the dimer of 29
was extended to n>7, a material was formed which was similar in the structure to
a -sheet. In the extended dimer, multiple intramolecular hydrogen bonds were
formed between the two oligomers. This creates an organized aggregation
pattern, creating a material, that is much less soluble in solution than the
monomeric units.

Figure 3.2 Hypothetical octamer structure 29, n=8 and a stereo diagram of
the calculated interaction between 29, n=8 and HPO42-.
Enantiomerically pure C2 symmetric 1,2-diamines were used in attempts to
construct the chain of oligomers. The 1,2-diamines possess C2 symmetry as the
only point group operation. The same is true for the helix. Helical symmetry
should result when an anion is present to bind to the oligomer (see figure 3.2).
Multiple hydrogen bonds could form with the multiple hydrogen bond acceptors
on the oxoanion. This structure would fold with a helical bias like natural proteins.
Another positive aspect to using C2 symmetric subunits is the simplicity of the
construction. Synthesis should be based on N-C amide bond formation. The
constituent 1,2-diamines due to the C2 symmetry avail both nitrogen atoms as
nucleophiles. If either one reacts the same chiral product is obtained. The work
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began with commercially available 1,2-diaminocyclohexane, however the work
will continue with synthetically available 1,2-diaryl-1,2-diaminoethanes and other
C2 symmetric diamines. Another graduate student will continue this project in our
labs.
In this work we sought to perturb the conformation of the oligomers by
changing the media and introducing guest anions. The preferred method of
detection of these conformational changes was CD spectroscopy. CD can be
used to monitor the conformation of biopolymers in solution.1 Bands in the CD
spectrum at 190 and 220 nm that correspond to the λmax of the amide carbonyl of
an α-helix.1 These peaks are mostly independent of the amino acid composition.
Given this, a similar change would be expected from a secondary structure
formation in oligomers of 29. The sensitivity of this oligomer to changes in anion
concentration as well as its own propensity to form a conformation analogous to
a β-sheet should be investigated.
In the analysis of the CD results, the goal of molecular modeling
computation was to relate observed changes upon the titration of the oligomers
with anions to conformational changes that cause the observable. α-helix gives
3 distinctive peaks at 191, 207 and 221 nm. β-conformation gives two peaks at
194, and 216 nm.2 The CD spectra for an α-helix is essentially constant from one
protein to the next, assuming the absence of chromophoric side chains or solvent
interactions.1 This is the primary reason for the expectation that a conformational
change will result in an observable change in the CD spectra for polyamides.
The amide bond and the carbonyl are the primary chromophores that
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generate CD signals. In the α-helix there are two transitions, which are aligned,
parallel and perpendicular to the screw axis of the helix. This generates the two
transitions at higher wavelength. Titration caused a change in the CD and NMR
spectra for both pentamers. For extended oligomers of 29 the material was
expected to form helices, which should increase the R-value, or the rotation of
light in one direction per mole of oligomer, for that oligomer. CD titration data was
more complicated than this, so further investigation of the bound and the
unbound structures was needed.
3.2 Biomimetics
Oligomers of 29 were synthesized to mimic the conformations of biological
molecules. Biologically derived molecules show the ability to greatly accelerate
reactions with a phenomenal specificity, and to tightly and specifically bind to
large or small molecules. These extreme properties drive chemists to study
biomolecules to understand and mimic their properties. Biomolecules can
generate much complementary surface area that is useful in forming pockets to
catalyze or bind to specific molecules. The architectural diversity that comes from
α-amino acids is rather remarkable. A diverse array of interesting globular
structures comes from chains of α-amino acids. RNA, and proteins take
advantage of conformational motifs that generate stable 3D structures that can
do interesting chemistry.
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3.2.1 Design of a biomimetic host

Figure 3.3 Structurally related helical foldamers.
Foldamer is a term that can be used to describe any polymer that has a
strong tendency to adopt a general conformation. In general, the conformation is
repetitive, but not necessarily the sequence. 3 In the design of 29, a goal was set
for a system which would be simple to make, but would still lead to complex
structures. Modeling of 29 and comparison4,5WRWKHDERYH-peptides, in Figure
3.3, and the natural proteins led to the notion that 29 would also form helices
similar to those of proteins. Calculations, of the above systems, predict that they
are relatively rigid and form tight helices. In Figure 3.2 a hypothetical octomer is
produced with Monte Carlo simulations. The conditions of the modeling are
described later in section 3.4.1. The general conditions included the use of the
Amber* force field and the GB/SA solvent model for water; modeling procedure
are described in detail in sections 3.4.2, and 3.4.3. The octamer structure was
not tightly constrained and could form a pocket to nearly encapsulate the
modeled oxoanions. Monte Carlo simulations showed multiple low energy
conformers with significant coverage of the phosphate molecule. Changing the
solvent model from water to chloroform only improved the energy of the binding.
The polar oligoureas formed weak hydrogen bonds that should collectively work
to bind the oxoanions. An oligourea appeared well suited for anion recognition.
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The modeling studies showed encapsulation, via helix formation in Figure
3.2. The encapsulation was nearly complete with an oligourea only 8 units long.
Multiple hydrogen bonds formed with the oxoanion allowing the oligourea to
mimic the normal solvation shell of the oxoanion in a hydrogen bonding solvent.
Ordering in the binding pocket appeared to improve upon use of a single
enantiomer of trans-1,2-diaminocyclohexane, implying there could be some
cooperativity in the helix formation. Oxoanions are more difficult to coax into
intermolecular association with de novo molecular guest than cations, the size
and directionality of the solvation shell requires a complex molecule, from a
design and a synthesis standpoint. Oxoanions also possess large negative free
energies of hydration, keeping them hydrated instead of in an associated state.
Foldamers are able to form complex complementary surface area from a
relatively simple linear chain. Despite the large and negative free energy of
hydration, many biological foldamers6 are able to bind strongly to oxoanions.
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3.2.2 Foldamer concept

Figure 3.4 Ramachandran diagrams show the limited conformational space
in polypeptides. Two state behavior in chiral conformational space results
from this limited chain entropy.
Biological systems use the foldamer concept to package genetic
information in DNA oligomers. In DNA, chemical diversity at the level of the
primary sequence transmits information. This system compacts, folds the
information for storage, and allows the information to be read, copied, and
repaired. As a foldamer, DNA can behave like a homogeneous polymer despite
the fact that it is composed of four different monomers in a plethora of different
sequences. Likewise foldamers (α-helices, β-sheets, β-turns, β-barrels, and Ωloops) in proteins effectively allow 1D sequences to birth complex, functional 3D
architectures. Diversity in protein conformation is surprising when one considers
the limited nature of Ramachandran conformational space in peptides (see
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Figure 3.4).7 On the other hand, the peptide foldamer may be useful for
biological architecture only because its conformational space is limited. This may
be a general statement regarding the dynamic behavior of molecules that fold in
biologically relevant ways. Limited conformational space appears to be an
important factor in the formation of the biological foldamer and the suitability of
the foldamer to strong 2D structure formation, not only in proteins but also in
RNA.8
3.2.3 Foldamer models
These general principles can be applied to the design of non-biological
oligomers. Biological oligomers are not the only interesting, or biologically
relevant foldamers other foldamers have been formed from oligoamides
constructed from β-amino acids or β-peptides.9 The conformation of these
peptides was studied and compared to the natural α-peptides using the diversity
inherent in the α-peptide system. Several examples of biological activity and
therapeutic application of β-peptides have been found. One of Gellman's
cyclopentane derived β-peptides, β-17 displayed unique antibacterial activity in
its ability to kill the drug-resistant strains, Enterococcus faecium and

Staphylococcus aureus.10 The antibiotic activity appears to derive from the fact
that the β-peptide folds into helix which disposes hydrophobic side chains on one
side and cationic side chains on the other, similar to a family of antibiotic
peptides, the magainins. Seebach has also found biological activity in β-
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peptides.11 These materials obviously resemble their natural peptide cousins
and interact with the body in a manner similar to the α-congeners.

Figure 3.5 Foldamer-based molecular recognition.
If β-peptides are scientifically interesting, 9 other conformationally
constrained oligomers bearing peptide-like properties should be considered in
this regard as well. In fact some other non-peptide foldamers have been studied
and were found to form some unique and interesting 3D forms. 12-15 The
foldamer in Figure 3.5 was synthesized by Moore to demonstrate that foldamers
could be used to establish cooperative molecular recognition.12-15 Work with
this foldamer established that this class of materials could be used to form a
three dimensional cavity, for pocket binding of guest molecules. In these wellbalanced systems, the electronic nature of the internal space, the external
surface and the solvent molecules differed little. Furthermore, the chiral
conformation in the foldamer came from the chiral guest. This foldamer differs
from the ideas involved with the foldamer system 29. Moore’s foldamer explores
achiral hydrophobic spaces and chirality is induces in the molecular host by chiral
guests; see Figure 3.5. In contrast, in the development of foldamer 29, the
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objective was to achieve a chiral conformational change by binding an achiral
anion to a chiral foldamer; see Figure 3.2.
3.2.4 Building a biologically-inspired foldamer
Enantiomerically pure trans-1,2-diaminoethane units were used as
building blocks for the synthesis of 29. (1R,2R)-1,2-diaminocyclohexane and
(1R,2R)-1,2-diamino-1,2-diphenylethane (to be reported elsewhere) were used
as monomers. The functionality of the monomers was similar to peptides both
contain sp2 hybridized hydrogen bond donors, the amide or urea NH
functionality, and hydrogen bond acceptors, the carbonyl oxygen. The material
was applied to a foldamer-based molecular recognition of oxoanions. Here, the
local chirality of the monomer, C2, predisposes the chain to take on
conformations capable of doing molecular recognition.
In the proposed interactions between an oligourea and biologically
relevant anions, the urea N-H functionality will point toward the axis of the helix
and the aliphatic portion of the oligomer will occupy the perimeter of the helix. In
suitable solvent, the guest will be enveloped by the oligourea. Conformational
tendency in these oligomers should be controllable. The chiral 1,2-dimino ethane
derivatives will have a tendency toward helicity, if each unit is either (R,R) or
(S,S). In this manner, by virtue of its conformation, the oligomer will define the
physical-chemical nature of inner and outer space. We see this property as
potentially useful to the development of smart solids for chemo sensors and drug
delivery of biologically relevant anions.
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The molecular recognition scheme outlined above is biomimetic. The
proposed conformational bias in the oligomers under consideration involves the
principle of hydrogen bond cooperativity. This important characteristic of
biological oligomers consists of numerous weak interactions contributing
additively to a bioactive conformation.16,17 The establishment of each atomic
contact between the helix and the guest molecule should contribute
synergistically to the stability of the ensemble.
Designed molecular recognition between large, non-biological and
biological molecules has not received enough attention. Usually investigators
pursuing molecular recognition target small guests toward small hosts. Likewise,
the most important targets in the pharmaceutical community fall under the
category of ‘small molecule drugs.’ Minimally complex molecules work well when
searching for drug candidates because they are well suited for molecular libraries
and high throughput screening. However, the majority of life processes involve
the chemistry of polymers or oligomers. This principle is self-evident when one
considers the central importance to the organism of materials like DNA, RNA,
proteins, polypeptides, polyketides, tubulin, collagen, hyaluronan (and other
oligosacharides) and lipid membranes. A living cell is not a solution of proteins
and other biological substances; a cell is a gel due to the plethora of interactions
between biological molecules. Clearly, most biochemical processes and much
molecular recognition in the biological context occur at interfaces between solid
and solution. There is much space for scientific thought and molecular design
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between 'small molecule' drugs and the kind of substances that biologists and
chemists consider oligomers.
3.3 Synthesis
A foldamer, 29 was synthesized using the synthetic intermediate (1R)-1amino-(2R)-2-isocyanatocyclohexane as a template for the formation of an
oligourea. Using different protecting and activating groups different oligomers
were synthesized. Synthetic problems prevented the facile synthesis of
oligoureas greater than 4 units in length. Long oligoureas were needed to be able
to form a helix around the oxoanion. This conformational change would result in
a detectable changes in the circular dichroism spectra of the complex. To
overcome these problems, isophthalic acid, and 1,3-phenylenediisocyanate were
used as spacers to increase the chain length. Amine protection with Boc
anhydride and ethyl trifluoroacetate was used to control reactivity at either end of
the molecule to enable effective elongation of the oligomers. Isophthalic acid was
mono protected as the methyl ester. Convergent syntheses after each major step
should have led to new binding candidates.
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Figure 3.6 Synthesis of a differentially protected dimer.
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H2N

Figure 3.7 Crystal Structure of 33
Trans-1,2-Diaminocyclohexane was dimerized by adding 1trifluoroacetamido-2-aminocyclohexane 32, slowly to a solution of triphosgene,
converting the unprotected amine into an isocyanate. This isocyanate reacted in
a facile manner with 31 when the amine was added quickly to the isocyanate of
32. This material could be crystallized from methanol/ethyl acetate in 60% yield.
The crystal structure is shown above in Figure 3.7. The differentially protected
dimer, 33, could then be quantitatively differentially deprotected with the use of a
20% v/v solution of TFA/CH2Cl2 for removal of the t-Boc protective group and 0.2
N barium hydroxide in 50% aq. methanol for removal of the trifluoroacetamide
protective group. Deprotection of the trifluoroacetamide protection group gave a
chloroform soluble amine, 35, which was used to proceed further in the
synthesis.
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Figure 3.8 Synthesis of protected pentamers with spacers
Spacers were employed to make pentamers 39, and 44 after the
heterocoupling of 34, and 35 with triphosgene did not result in a well-defined
chemical species 60 (see Figure 3.9). Dimer 33 and pentamers 39, and 44 gave
well-defined 1H, 13C, and MALDI-TOF spectra. 34 reacted in a facile manner with
isophthaloyl chloride to form pentamer 39 in good yield. 31 was also reacted with
isophthaloyl chloride, and 32 condensed with 1,3-phenylenediisocyanate in good
yield to form their respective trimers.
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Figure 3.9 Synthesis of differentially protected oligomers
The methyl ester 37 was easily deprotected with 4 equivalents of lithium
hydroxide, converted to the acid chloride and reacted with the trifluoroacetamide
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protected dimer, 34, forming a differentially protected pentamer. Unfortunately,
this material was not well defined by MALDI-TOF, despite the fact that the
symmetrically protected pentamer 39 above was well defined. NMR of 59 had 8
amide type NH peaks, but purification of the material by flash chromatography
gave a material which was similar to 35.
Hetero-protected oligourea 60 was not obtained by using triphosgene or
carbonyldiimidazole coupling regents. Current work on the synthesis of these
oligomers is currently being done by others in the group. This work is briefly
discussed in the addendum. Carbonyldiimidazole produced only dimerized
product and was ineffective at producing a heterocoupled product. Triphosgene
was also ineffective at producing a heterocoupled product due to the low
solubility of Tfa-protected dimer 34. A protected diamine has been synthesized
activated and isolated using p-nitrophenyl-chloro-formate as an activating
reagent.
The sensitivity of the conformations of free amine derivatives 40 and 45 to
the concentration of PO4 were compared to those of shorter derivatives 43 and
38b (Figure 3.26). These studies should have evaluated the ability of dimer 33 to
function as substructural units in the molecular recognition of oxo-anions. The
linkers were long enough to allow the two ends of the oligomer to meet in
modeling studies, and should be more effective than a simple homocoupled
oligourea from a dimerizing activating agent like carbonyl diimidazole.
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3.4 Computation and modeling
Computation was used in the design and analysis phases of this research.
Modeling directed the synthesis toward oligoureas that were helical in the
presence of phosphate (see Figure 3.2). Modeling also sought to investigate the
possible two-state behavior of the oligoureas.
3.4.1 Monte Carlo simulations
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Figure 3.10 Monte Carlo simulation of the low energy structure pentamer 40
with HPO42Monte Carlo simulations done on 200 trial conformations of 40,
procedures, and theoretical details as described below, found 12 low energy
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conformations within 3 kcal/mol of the lowest energy structure shown above in
Figure 3.10. Variations between the low energy conformers, found by the Monte
Carlo search routine, of phosphate-bound pentamer were small. Structures
lacked the length to wrap the phosphate in a helix, which would require the
oligomer to wrap greater than 360° around the phosphate. 40 formed an
interesting cup like structure in which the pentamer wrapped the phosphate, and
the phenyl ring held the phosphate in the cup. Other conformers moved the
position of the phosphate in the cup, or moved the amine of the terminal
cyclohexane ring in or out of the cup.
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Figure 3.11 Pentamers 45, 40 with solvent exposed surface (1.4 Å probe
radius)
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Figure 3.12 Description of conformational searching with Monte Carlo
simulations
One of the primary goals of molecular modeling is to find the global
minimum structure for any given oligomer. Unfortunately, because of the way that
modeling programs find energy minima, the structure that results may not be the
lowest energy conformation for the molecule. The lowest energy conformation
given by the minimization can be referred to as the global minimum. The global
minimum shown in the above figure is the deepest energy well. Local minima,
shown above, as the smaller wells can also be important for chemical reactivity
and, if the barriers to the interchange between the different conformational
isomers are low, then the molecule may spend part of its time in one or more
local minima.
Monte Carlo simulations explore the dynamics of the molecule. Most
minimization programs calculate a derivative of the energy at a particular
conformation. The conformational variables are then adjusted based on that
derivative. This allows for fast determination of minima. Using this technique local
minima are found if starting from a or b in conformational space or the global
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minimum if starting from c. Users of modeling software defeat the predisposition
to achieve local minima by intelligent choices of starting points. Monte Carlo
simulations attempt to simulate heat energy to explore the dynamics of the
molecule. A Monte Carlo simulation18 takes a set of rotatable bonds and applies
a random change, such as a rotational increment between 0 and 360°, or an
atom displacement. If there are no high-energy steric interactions, then a
minimization is run, and the energy compared to the lowest previously found
minima. If a minimum structure is found then this is the new starting point and
this structure is adjusted. Otherwise, the Metropolis algorithm19 is used to
determine if the trial configuration is accepted as the new starting point.20 This
algorithm generates a random number between 0 and 1, then compares this to a
probability given by the Boltzmann distribution. exp(-∆Ei/kT) If the random
number is smaller, then the new conformation is accepted as the new starting
point.

Figure 3.13 Pentamer 40, 45 with arrows to indicate the dihedral angles
simulated in Monte Carlo calculations
Monte Carlo simulations ran trial configurations of pentamers 40, and 45
with the Amber* force field, and the chloroform solvent parameter set.
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Calculations set to find all conformations within 50 kJ/mol of the found global
minimum. Pentamer minimizations calculated in a fashion similar to those of the
Ramachandran plots shown below. Monte Carlo simulations ran with the
constraints for torsinons marked with curved arrows, seen in Figure 4.13 above
to reduce multiple high energy conformers and reduce the time required to find
low energy conformers.
3.4.3 AMBER*
The AMBER* torsional parameterization set was employed with the
program Macromodel Interactive Molecular Modeling System Version 5.0® to
determine the low energy conformation of the oligomers. Amber is a molecular
mechanics force field that is widely used for modeling biological oligomers. Like
most molecular mechanics force fields this one is quite dependent on
experimentally determined variables. Stability is conferred to the molecule if it
can come close to the optimal bond length, bond angle and dihedral angle. A 126 parameter set is used to mimic the effects of the van der Waals forces. The
sum of these effects gives an overall energy for the conformation of the
molecule. This and other improvements in the parameters for the peptide
backbone allow for optimal results for peptides.
3.4.4 Solvation treatment
Solvent can have a major affect upon the relative energy of many
substances. Macromodel uses the GB/SA model to describe the effects of
solvent. A chloroform parameter set was used for the analysis of oligomers of 29.
The free energy associated with solvent, G sol, is the sum of three terms,21
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including a solvent-solvent cavity term, Gcav, a solute-solvent cavity term, GvdW,
and a solute-solvent polarization term, G pol (Gsol = Gcav + GvdW + Gpol). For
saturated hydrocarbons Gsol is linearly related22,23 to the solvent accessible
surface area (SA). Gcav and GvdW can be calculated by a determination of the
solvent accessible surface area and the solvation parameter for each atom. The
other parameter modifies the electrostatic attraction of a system of widely
separated charges. The generalized Born equation21 relates the dielectric
constant of the solvent to a contraction of the attractive or repulsive forces of
separate charges. An article21 by Still and Thompson describes well the
generalized Born equation and its relation to G pol. 3.6.11 Molecular modeling of
oligomers (29)
Oligomers were modeled using MacroModel,24 a molecular mechanics
program to find optimum (minimum energy) conformations. Molecular mechanics
uses sets of force fields that have been optimized using experimentally, and ab

initio determined molecular constants. Molecular modeling is primarily used to
examine molecules that are large of have many degrees of freedom that make
them difficult to minimize using more computationally intensive methods. A force
constant is used to put an energy value to torsion and bond length parameters.
Molecular mechanics also uses experimentally determined values for the van der
Waals radii and electrostatic attractions are also used to determine the low
energy structure.
Monte Carlo simulations were run with unbound pentamers 40 and 45.
Simulations gave the conformational energy minima shown by the conformers in
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Figure 3.11 above. These structures had varying degrees of compactness and
helicity. Pentamer 45 appeared to be more stable in the most compact forms.
Pentamer 40 appeared to be more stable in less compact conformations. In
pentamer 45, each dimer arm is conformationally stabilized with a 7-membered
ring formed between the amide NH of one urea and the carbonyl CO of another.
40 was not as globular in its minimum energy conformation, and the two dimer
arms crossed each other at a higher angle than that of 45. See below for a
diagram of the difference between 45 and 40, in Figure 3.14. The change in the
angle of the two dimer arms and the chain length caused by the change from an
amide to an urea around the phenyl ring caused the molecule to go from a tight
ball to a molecule that looks like a set of arms crossed.

Figure 3.14 Diagram of position of cyclohexane arms in the pentamer 40
and 45
Like the biological molecules, the change in the dynamic globular structure
of the two pentamer bodes a change in the rotation of circularly polarized light.
Despite the small size of the molecules, they do appear to have a definite
conformational preference. The ball shaped conformation of structure 40
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appeared to have little effect on rotationally polarized light, but the crossed arms
of the conformation of pentamer 45 had a larger effect.
3.4.5 Conformational motifs and predictions of two-state behavior
Ramachandran plots, like the one shown in figure 3.4, indicate
conformational propensity in complex conformational space as a function of two
rotatable bonds. Limiting the conformational space is very important to biological
molecules. This limited conformational space governs the ability of biomolecules
to adopt native (functional) or extended (denatured) states. Using this type of plot
Ramachandran and coworkers7 defined an upper limit on the conformational
space of peptides. Ramachandran defined the atoms in his dipeptide as spheres
that have a hard shell and are not allowed to penetrate the shell of another atom.
If a conformation causes two atoms’ shells to penetrate then the conformations is
not allowed. Large portions of the map are excluded using this method, but the
sections that are not excluded can be used to categorize the various folding
patterns in peptides. It is also possible to use the chart to predict if certain
folding patterns are or are not allowed. The plot predicts the common righthanded α−helix, shown in the bottom left hand corner of the plot in Figure 3.4, as
an allowed structure. The not so common left-handed helix, in the small lightly
gray patch in the upper right-hand corner was predicted as an allowed but rare
structure. The gamma helix lies outside the outer limit for the minimum contact
distance and therefore is not allowed. The extended or β-structure labeled part of
the plot in allowed conformational space for the dipeptide. It is difficult to see in
the plot in Figure 3.4 but the α-helix has a deeper well (more stable) than the β-
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structure. However, the β-structure covers more area in conformational space.
Therefore, the β-structure should be entropically favored and thus favored at
higher temperatures. Basically this gives rise to the two state behavior of peptide
and protein folding.
Peptides that are longer than two amino acids in length have long-range
steric interactions.25 The long-range interactions of larger peptides impose
further restrictions on the motion of the peptide. The packing of the chains of 29
should increase the order of the molecule with increasing length. The
Ramachandran plot data for 56 showed a conformational preference for one of
the four energy wells, and changing the solvent increases this preference.
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Figure 3.15 Ramachandran plot of the rotation of Φ1 and Φ2 in structure 56
using the GB/SA chloroform parameter set.
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Figure 3.16 Ramachandran plot of the rotation of Φ1 and Φ2 in structure 56
using the GB/SA water parameter set.
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Figure 3.17 Ramachandran plot of the rotation of Φ1 and Φ2 in structure 56
+ 2HCl using the GB/SA water parameter set.
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Figure 3.18 Low energy intermediate
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Ramachandran plots of the dimer 56 showed the effects of conformation
and solvent upon the hydrogen bond strength. Figure 3.16 showed that
chloroform increases the effect of the intramolecular hydrogen bond on molecular
conformation. In Figure 3.16 some of the energy wells are much deeper than
others. The conformations correspond to the establishment of hydrogen bond
donors and acceptors. The conformation shown in Figure 3.19 was one of the
common energy wells shown in the RC plots. The seven member ring
constrained by a hydrogen bond is also found in some of the high energy
intermediates, presumably due to high energy atom contacts from the proton and
nitrogen which are pushed too close to the amide NH. In Figure 3.16 and 3.17,
the RC plots showed a decreased influence of the intramolecular hydrogen bond
due to the solvent change from chloroform to water on the molecular
conformation. The molecule can more easily explore four different regions of
conformational space in water. Conformation appeared to be controlled primarily
by the steric arguments.
Folding in apolar solvents appears more promising, and some helix
inducing alcohols like trifluoroethanol or hexafluoroisopropanol may induce these
conformational changes in mostly aqueous solvents.26-28 The RC plot of the
dimer in chloroform solvent gave low energy conformations in a smaller portion of
the chart, with higher barriers between different energy wells. Some of the
regions in the chart were explored with molecular modeling to identify forms that
will come from them. The α−UHJLRQDQGWKH-regions of the chart were indicated
in Figure 3.17. The determination of α- versus β-regions was determined by the
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analysis of the compounds modeled from the crystal structure of the dimer 33.
Regardless, the Ramachandran space characteristic of the dimeric oligourea hint
that conformational motifs reminiscent of natural polypeptide chains should be
possible for the planned oligomers. The hypothetical structures below were
modeled and the dihedral angles of the resulting structures were sampled.

To find the Ramachandran plot for a dimer of the oligomer 29, 56 was
minimized and the two dihedral angles for the two CN bonds immediately
adjacent to the urea, φ1, and φ2 were adjusted. First φ1 then φ2 is rotated from 0°
to 360° in increments of 10° to make 1296 energy measurements. Energy is
determined for each conformation, and the data can be plotted on a contour plot
like that of the well-known Ramachandran plot for φ, and ψ in proteins.
3.4.6 Protein like conformations of oligourea (29) n=8

Figure 3.19 Extended dimer crystal structure
Modeling of oligourea 29 showed the propensity of the molecules to mimic
prRWHLQIRUPV2IWKHVHIRUPVWKH-sheet seems most obvious. The protected
dimer formed a thick gel when added to halogenated solvent with a small percent
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DOFRKRO7KHVWUXFWXUHLQ)LJXUHVKRZVDVWDEOH-sheet like structure found
for 29 n=8. This structure came from another modeling study. Two adjacent
molecules of 33 from the crystal structure shown in Figure 3.7 were deprotected
and elongated to eight units in length. They were then modeled with an Amber*
force field, and water was modeled by the GB/SA solvent parameters. The
UHVXOWLQJFRQIRUPDWLRQRIVWUXFWXUHVUHVHPEOHGDVHWRI-sheets in the way they
formed a short network of perpendicular hydrogen bonds. The resulting
aggregate was highly stable and could form a gel in solution. Urea compounds
often form gels in solution. These gels may mimic the protein-protein interactions
of the cellular environment.

Figure 3.20 Hexadecamer helix conformer
Figure 3.21 shows a helical conformer of 29 n=8 with the right hand end
acetylated. The above structure was a highly favorable conformer found through
molecular modeling, which was lower in energy than the β conformation shown in
Figure 3.20. Rotating the CN bonds so that NH bonds made contact with unit
N+1 formed the α-structure. A minimization was then carried out using the same
parameters as the β conformer, resulting in the conformation shown in Figure
3.21.
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3.5 Evaluation and conclusions
3.5.1 CD titrations
In the modeling phase of this experiment it was hypothesized that upon
addition of significant amounts of oxoanion, oligomers would bind and cause a
gross change in the circular dichroism spectrum. CD spectroscopy required a low
concentration of the oligomer for analytical determination of the CD spectra. To
test the binding of the pentamer to phosphate an organic soluble source of
phosphate was required. The tetrabutyl ammonium dihydrogen phosphate salt
was an excellent source for solvents from methanol to acetonitrile to chloroform.
Although the oligomers were modeled in a chloroform solvent field, that solvent
was not transparent to UV light at wavelengths of less than 240 nm. The window
of wavelengths in which urea absorbs is 200 to 240 nm; therefore this is the the
region where we would like to detect the CD spectra. Acetonitrile is transparent
for this section of the UV spectrum, so it was used for this titration. Titration
methodology to detect binding of deprotected pentamers 40, and 45 is described
later in section 3.5.2.
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Figure 3.21 CD titration of the pentamer 45.
There appeared to be two different binding constants for pentamer, 45,
detectable in acetonitrile. The first appeared around 0.02 mM, phosphate and the
second around 0.2 mM. The concentration was ~0.01 M pentamer. In water with
Na2PO4, this pentamer had no detectable change in its CD signature. Binding for
this molecule seemed improbable in water, but comparison to the amide
pentamer augmented the argument that binding was present in acetonitrile.
Titration had significant drift due to error in the measurement of CD spectra. Error
bars are included in Figures 3.22 and 3.23 for CD measurements in the titration
of amide pentamer 45 and 40. Error was calculated for each measurement, and
appears in graph to ± 2 standard deviations. Each data point was measured
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three times and the standard error calculation was made for determination of the
error. This titration was repeated 2X with both shown on the graph below.

Figure 3.22 CD titration of pentamer (40).
Pentamer 40 was titrated under the same conditions as pentamer 45, but
gave a greater CD response. The response for 40 was enhanced for the second
binding constant by a precipitation phenomenon that did not occur for 45. The
binding constant for pentamer 40 was similar for similar concentrations of
oligomer and phosphate versus those for pentamer 45. The first and second
binding constants occurred at 0.02 mM and 0.2 mM. Error bars for CD data of
pentamer 40 are similar in absolute value to those for 45.

93

Figure 3.23 Jobs plot for amide pentamer (40).
Jobs plots are useful tools to determine the stoichiometry of binding for a
particular binding curve. In the Job’s plot the total concentration of the host and
the guest are not varied, but the ratio between the two is. The ratio with the
maximum observable is the stoichiometric ratio for the binding constant of
interest. In the above Jobs plot, the maximum observable occurred at a ratio of
0.5/0.5 H2PO4/pentamer. Therefore, the binding constant of 0.02 mM
corresponds to a 1: 1 binding stoichiometry of phosphate to pentamer.
Binding stoichiometry for pentamers appeared to vary between the two
concentration regions in the two titration plots. The binding constant was similar
for 45 and 40, so there is no reason to believe there is variation between the two
pentamers. Jobs plot data for pentamer 40 were collected at concentrations
between 0.02 and 0.08 mM pentamer. Total concentration of the anion and the
pentamer was kept constant at 0.1 mM. This range of concentrations puts the
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titration after the endpoint of the first binding constant and before the midpoint of
the second binding constant. This implies that the first binding constant was the
predominant factor in the determination for the Jobs plot stoichiometry.
3.5.2 Experimental method for determination of the binding of C2 symmetric
hosts, 40 and 45, to phosphate by circular dichroism spectrometry.
Pentamer 40 (3.0 mg, 4.7 µmol) was dissolved in 50 mL of a 1/49 mixture
of methanol/acetonitrile to give a 9.5x10-5 M solution of 40. This was solution A.
Another solution consisted of tetrabutylammonium dihydrogenphosphate (39.1
mg, 115 mmol) in 100 mL of a 1/49 mixture of methanol/acetonitrile, respectively,
to give a 1.2x10-3 M solution of phosphate. This was solution B. The phosphate
solution B was added to ALQZLWKDQDXWRSLSHWWHLQ/LQFUHPHQWV6ROXWLRQZDV
mixed in the CD cuvette. CD spectra for the solution in this cuvette were scanned
2x between 250 and 200 nm and recorded. Data was monitored along the peaks
for both pentamers. Nitrogen was flowing though the spectrometer at a rate of
20-30 mL/minute. A standard error calculation of
Equation 3.1 s =

( xi − x ) 2
∑
N −1
i =1
N

was used to calculate the error in three measurements of CD data. Another
titration was done but at different concentrations of phosphate so was not
included in the calculation. Individual error calculations were done on each point
in the other titration.
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3.5.3 NMR titration of oligomers

Figure 3.24 NMR titration of oligomers with NaH2PO4, monitoring the protic
ammonium peak
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Figure 3.25 Oligomers tested for binding to phosphate by NMR methods
NMR titration of the oligomers verified the binding constants obtained
through CD titration methods. Four oligomers (38b, 40, 43, and 45) tested
positive for binding to phosphate by NMR methods. The change in the NH peak
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height and subsequent disappearance of that peak indicated a change in the
chemical shift of the peak. The peak was not detected elsewhere, but evidence
indicated that the peak should be found near the water peak and therefore
undetectable. The NH peak of interest was the R-NH3+ peak for the oligomers.
The peak was a single broad peak as a result of fast H+ exchange that comes
with the acidity of the ammonium protons. Amide and urea protons were slightly
broadened doublets. Before the titration, the ammonium peak was approximately
1.5-fold the size of the peaks corresponding to the amide and urea protons. This
was the expected ratio of protons derived from the structure.
Changes in solvent structure explained the up-field movement of the NH
peak. The ammonium protons were solvated in solution by multiple water
molecules. Upon binding to phosphate, the water structure was broken and fewer
electron-withdrawing hydrogen bonds could form to the oligomer. A more
electron-rich proton resulted from this change in solvent structure, and therefore
the chemical shift of the proton moves up-field.
The three oligomers, included above in Figure 3.26, have one similar
binding constant between 12 and 17 mM. The two urea oligomers 40, and 43
share another binding constant at 3 mM. The data set for 38b indicated a
binding constant similar to those for the other three oligomers tested. Variability
in the data made the results inconclusive.
The urea pentamer, 45, and trimer, 43, precipitated in solution, but
concentrations remained high enough to determine peak integrations. The
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internal reference for the NH proton integration was a phenyl CH proton.
Therefore, the precipitation did not bias the results.
3.5.4 Experimental method for the determination of the binding of C2
symmetric hosts, 40 and 45, to phosphate by 1H NMR.
Two solutions were prepared for this determination. For solution A, 11.7
mg of free amine 40 was dissolved in 0.04 mL 1 N HCl, 0.49 mL H20 and 1.1 mL
methanol-d4. This solution was 71% 1H, 29% 2H for the exchangeable protons,
so amides should appear at 71% of the expected height for a solution in an
aprotic NMR solvent. For solution B, 28.0 mg of NaH2PO4 was dissolved in 0.53
mL of H2O and 1.1 mL methanol-d4. The concentration of sodium dihydrogen
phosphate was 146 mM. Solution B was added to solution A and the proton
NMR spectra was acquired under presaturation conditions. The 90° pulse width
was determined for the solvent mixture, and saturation delay time was optimized.
Aliquots of solution B were added to the NMR sample and shaken. The NMR
was shimmed after each change in phosphate molarity. Peaks at chemical shifts
7.8, and 8.3 were integrated and the ratio of the two peaks changed of changing
concentrations of NaH2PO4. The ratio of the integrations of the two peaks was
monitored over the course of the titration. Care was taken in order to make the
integrations consistent over the course of the titration.
The above titration was repeated for pentamer 45. The solvent conditions
of solution A were matched for solution C, which contained 8.3 mg (12.4 µmol) of
45 in 0.028 mL of 1 M HCl, 0.340 mL of DI water and 0.742 mL of methanol-d4

98

for a total of 1.11 mL solution of 11.2 mM concentration. Solution B was also
used for this titration. Peaks at 6.0 and 7.8 were used to monitor the titration.
3.6 Synthetic procedures and data
3.6.1 (1R, 2R)-1-(N-t-butyloxycarbonylamino)-2-aminocyclohexane (31)29
NH2

30

BocOBoc
NH2 CHCl3

NH2
NHBoc

31

Figure 3.26 (1R, 2R)-1-(N-t-butyloxycarbonylamino)-2-aminocyclohexane
(31)
(1R, 2R)-(+)-trans-1,2-diaminocyclcohexane, 30, was resolved to optically
pure (R,R) or (S,S) by a literature procedure.30 The optically pure diamine is also
available commercially, but expense prohibits buying this material in bulk. To a
cooled solution of 30 (3.36 g, 29.5 mmol) in CH2Cl2 (100 mL) was added a
solution of Boc anhydride (3.0 g, 13.7 mmol) in CH2Cl2 (100 mL) slowly over a
period of 4h. The reaction mixture stirred overnight at RT. Water (25 mL) was
added in order to dissolve the precipitate. After separation, the organic phase
was concentrated under reduced pressure and the residue dissolved in ethyl
acetate (25 mL). Water (25 mL) was added, the mixture was acidified to pH=5
with 2N HCl and the bis-protected diamine was extracted with ethyl acetate (2 x
20 mL). The aqueous phase was adjusted to pH=10 with NaOH and extracted it
into ethyl acetate (3 x 20 mL). The combined organic layer was dried (Na2SO4)
and evaporated under reduced pressure to yield 31 (1.87g, 8.72 mmol, 30%

99

based on the starting diamine). Spectral properties of the product were identical
to those previously reported in the literature.29
3.6.2 Synthesis of N-(2-amino-cyclohexyl)-2,2,2-trifluoroacetamide (32)31
NH2
NH2
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EtOTfa
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NH2
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Figure 3.27 Synthesis of N-(2-amino-cyclohexyl)-2,2,2-trifluoroacetamide
(32)
To a cooled solution of (1R, 2R)-(+)-trans-1,2-diaminocyclcohexane (2.0g,
17.5 mmol) in CH2Cl2 (100 mL) was added a solution of ethyl trifluoroacetate
(0.94 mL, 7.97 mmol) in CH2Cl2 (50 mL) very slowly over a period of 4h. The
reaction mixture stirred overnight at RT. Water (25 mL) was added and after
separation, the organic phase was concentrated under reduced pressure and the
residue dissolved in ethyl acetate (25 mL) and water (25 mL). The mixture was
acidified to pH 5 with 2N HCl, and the bis-protected diamine was extracted with
ethyl acetate (2 x 20 mL). The aqueous phase was adjusted to pH ~9 with
Na2CO3 and extracted it into ethyl acetate (3 x 20 mL). The combined organic
layer was dried (Na2SO4) and on evaporation a white solid 32 as a white solid
(0.87g, 4.14 mmol, 24% based on the starting diamine).
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3.6.3 Synthesis of dimer (33)
1. Triphosgene, NEt3
NHTfa
NH2 2. NEt ,
3

32

NHTfa
H
N

NHBoc
NH2 31

H
N

NHBoc

O
33

Figure 3.28. Dimer forming reaction
(1R)-1-triflouroacetamido-(2R)-2-aminocyclohexane (2.04 g, 9.71mmol)
was dissolved in 40 mL CHCl3, 6 mL acetonitrile, and 3 mL triethylamine. This
solution was added to a solution of triphosgene (1.05 g, 3.53 mmol) in 14 mL
CHCl3 at a rate of 20 mL/h for the first two hours and 30 mL/h for the second
hour. During the addition the reaction was kept at a temperature of 15 to 20 Û&E\
the addition of small amounts of ice into a large ice bath. After addition was
complete the reaction was stirred for an additional 20 min The (1R)-1butoxycarbamate-(2R)-2-aminocyclohexane (2.08 g, 9.70 mmol) was dissolved in
12 mL CHCl3 and 2.2 mL triethylamine. This solution was added quickly in one
portion to the reaction to the previous reaction. The reaction was allowed to stir
overnight, and worked up with 2.0 mL methanol. The remaining CHCl3 was
removed with a stream of nitrogen. Trifluoroacetamide 32 and butoxycarbamate
31 protected diamines were removed by 3 extractions with a 10/15 solution of
saturated ammonium chloride and distilled water. Then basified with aqueous
sodium carbonate. The resulting organic layer was purified by crystallization from
ethyl acetate and methanol. The resulting crystals were thin needles that partially
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melted and turned brown at 241-242 °C. Subsequent crystallizations from the
same mother liquor also gave crystals of good purity.
H-NMR (400 MHz; CDCl3) δ 8.32 (1H, d),  +G  +G 

1

(1H, b) 3.62 (1H, m), 3.42 (1H, m), 3.35 (1H, m), 3.26 (1H, m), 2.22 (1H, d), 1.95
(2H, t), 1.82 (1H, d), +P  +V -1.4 (8H, m). 13C-NMR (100.4
MHz; CDCl3 + 3 drops CD3OD) δ 159.3, 157.6 (q, J=37.4 Hz), 156.9, 115.9 (q,
J=287 Hz), 79.3, 56.5, 54.3, 54.1, 51.8, 32.9, 32.6, 32,3, 31.1, 28.2, 24.9, 24.8,
24.7, 24.2. MALDI (MNa+) 473 (M-Boc+2H) 351. Anal. Calcd. For C20H33F3N4O4
C, 53.32; H, 7.38; N, 12.44 found C, 53.15, H, 7.27, N, 12.32. IR: 3320.7(s),
3276.1(m), 2940.6(s), 2856.4(m), 1700(s), 1685.1(m), 1639.7(s), 1450.3(w),
1367.2(w), 1322.6(m), 1276.2(w), 1253.1(w), 1181.6(s)
3.6.4 Synthesis of amide (37)

NHTfa
NH 33
1. .2 N Ba(OH)2
50 % aq. MeOH

O
NH

NHBoc

BocHN
O

1. 20% TFA
in CH2Cl2

O

O
N
H

N
H

+

35

H2N

1. NEt3, O

NH

N
H

NH MeOOC

COOMe

Cl

36

NHBoc

37

O

NH2

N
H

N
H

NHTfa

34

Figure 3.29 Synthesis a differentially protected oligomer.
To make the mono-deprotected dimer 35 the di-protected dimer 33
(0.6946 g, 1.542 mmol) was refluxed for 2 h in 10 mL of 1 M LiOMe in MeOH
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with 10% distilled water, and then evaporated under vacuum. The residue was
then dissolved with heating in EtOAc and distilled water. The aqueous layer was
removed and the organic was acidified with saturated NH4Cl. The organic layer
was extracted 6X with saturated NH4Cl. The combined aqueous layers were
basified with Na2CO3 (aq.) to pH 10. Extraction was done with EtOAc 3X. 35 was
obtained clean and was used as obtained in the next step (365.5 mg, 1.031
mmol, 67%).
Methyl,hydrogen isophthalate (50.0 mg, 0.278 mmol), prepared from the
dimethyl ester by a literature method32, was stirred in 5 mL distilled CHCl3 and
80 µL of oxalylchloride. N2 was allowed to flow over the reaction. Upon addition
of two drops of DMF, gas evolved from the reaction, and within 10 min the
reaction was complete. This reaction was evaporated under vacuum and
restored to normal pressure under N2.
To the acid chloride a solution of amine 35 (92.1 mg, 0.260 mmol), NEt3
(280 µL) was added drop wise at 0Û&7KHUHDFWLRQZDVVWLUUHGIRUKDQGGLOXWHG
with 5 mL CHCl3, and worked up with 2.5 mL portions of NaHCO3, and distilled
water. Product was crystallized from MeOH, EtOAc, and hexane. Crude material
was dissolved in MeOH, diluted with EtOAc, and precipitated with hexane, gave
54.7 mg (0.106 mmol, 41%) of clean amide 37.
H-NMR (400 MHz; CDCl3) δ 8.48 (1H, dt), 8.15 (1H, dt), 8.03 (1H, dt),

1

7.56 (1H, td), 3.70 (1H, m), 3.60 (1H, dt), 3.40 (1H, m), 3.26 (1H, m), 2.10 (1H,
b), 1.95 (2H, bm), 1.82 (2H, b), +E  +EP  +EP -1.4
(4H, m). 13C-NMR (100.4 MHz; drops CD3OD small amount of CDCl3) δ 171.6,
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170.5, 163.9, 161.2, 139.1, 136.1, 135.7, 134.5, 132.6, 132.3, 82.8, 59.8, 58.8,
57.4, 56.8, 55.8, 52.1, 4.12, 36.8, 36.6, 35.9, 31.8, 29.1, 28.7 MALDI (MNa+) 473
(M-Boc+2H) 351Anal. Calcd. For C27H40N4O4 C, 62.77; H, 7.80; N, 10.84 found
C, 62.51, H, 7.77, N, 10.62.
3.6.5 Synthesis of trimer diamide (38):
NH2
NHBoc
O
Cl

O

O

32
HN

Cl

BocHN

38

O
NH

NHBoc

NEt3

Figure 3.30 Synthesis of trimer diamide 38.
Isophthalic acid (87.9 mg, 0.529 mmol) was stirred in 5 mL methylene
chlRULGH2[DO\OFKORULGH /PPRO ZDVDGGHGXQGHUQLWURJHQ
pressure. Three drops of dry DMF caused the reaction to bubble vigorously, and
the isophthalic acid to dissolve. After 1 h the reaction was evaporated under
vacuum and dissolved in 5 mL methylene chloride again. 32 (288.9 mg, 1.348
mmol) was added under nitrogen, and stirred overnight. The reaction stirred
overnight at RT. Reaction was worked up with 3 mL brine and 10 mL EtOAc,
then 1 N HCl until the aqueous extract was acidic. The organic layer was dried
with Na2SO4 (anhydrous) and was crystallized with ethyl acetate and hexane.
H-NMR (400 MHz; CD3OD) δ  +V  +G  +G 

1

(1H, t), 6.65 (2H, d), 3.70 (2H, m), 3.38 (2H, m), 1.80 (4H, t), 1.67 (4H, m), 1.21.4 (5H, m), 1.22 (18H, s) 13C-NMR (100.4 MHz; DMSOd6) δ 169.1, 158.8, 136.2,
131.5, 129.5, 127.7, 80.2, 56.2, 55.1, 33.7, 33.4, 28.9, 26.4, 26.1 Anal. Calcd. for
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C30H46N4O6 C, 64.49; H, 8.30; N, 10.03; O, 17.18 found C, 64.47; H, 8.45; N,
9.91 IR: 3335.5(s), 3307.6(s), 2970.1(m), 2935.7(s), 2856.9(m), 1685.2(s),
1647.5(s), 1582.4(w), 1530.2(s), 1449.9(w), 1365.5(m), 1322.9(m), 1283.1(m),
1246.2(w), 1170.4(s), 1016.6(m)
3.6.6 Synthesis of pentamer diamide (39)
NH2

35

BocHN
H
N

H
N
O

O
Cl

O
Cl

NHBoc
H
N

NEt3

H
N

39

O

O

NH

HN

O

O

O
30% TFA/CH2Cl2

NH2

H
N

H
N

BocHN
H
N

H
N

40

O

HN

O

NH

H
N

H
N

H2N

O

Figure 3.31 Synthesis of pentamer diamide 39, 40.
Isophthalic acid (163.1 mg, 0.9818 mmol) was stirred in 5 mL methylene
FKORULGH2[DO\OFKORULGH /PPRO ZDVDGGHGXQGHUQLWURJHQSUHVVXUH
Four drops of dry DMF caused the reaction to bubble vigorously, and the
isophthalic acid to dissolve. After 1 h the reaction was evaporated under vacuum
and dissolved in 5 mL methylene chloride again. 35 (494.2 mg, 1.394 mmol) was
dissolved with 10 mL CHCl3DQG/1(W3 and added under nitrogen to the
isophthaloyl chloride, and stirred overnight. The reaction stirring overnight
proceded under RT conditions. Reaction was worked up with 3 mL brine and 10
mL EtOAc, then 1 N HCl until the aqueous extract was acidic. The organic layer
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was dried with Na2SO4 (anhydrous) and was crystallized with ethyl acetate and
hexane. The crystals of 39 could be deprotected by submission to a solution of
30% TFA in methylene chloride giving the free amine 40 upon workup.
H-NMR (400 MHz; CD3OD) δ 8.12 (1H, s), 7.84 (2H, d), 7.58 (1H, t), 3.98

1

(2H, m), 3.84 (2H, m), 1.98 (5H, dt), 1.81 (4H, m), 1.49 (4H, m), 1.40 (4H, b),
1.28 (1H, m), 1.22 (2H, b); EA: Anal. Calcd. For C44H70N8O8 C, 62.98; H, 8.41; N,
13.35; O, 15.25, found C, 62.63; H, 8.48; N, 13.07; IR (KBr Pellet): 3332.6(s),
2932.9(s), 2856.1(m), 2605.1 (w), 2498.1(w), 1686.4(s), 1531.5(s), 1449.5(w),
1366.2(w), 1319.3(m), 1280.1(w), 1174.0(m), 1040.6(w) 13C-NMR (50 MHz, 750
/&'&O3/&'3OD) 167.7, 159.8, 157.0, 134.7, 130.4, 128.7, 79.4, 77.5,
55.5, 55.1, 53.6, 53.3, 33.1, 33.0, 32.9, 32.3, 28.4, 25.2, 24.9, 18.9
3.6.7 Synthesis of trimer (43)
To a solution of 1,3-phenylene diisocyanate (0.1g, 0.63mmol) in CH2Cl2 (2
mL) was added the 31 or 32 (0.268g, 1.25 mmol) stirred for 10 min A white gel
was formed was washed with the ether. A white solid 42a / 42b was obtained in
quantitative yield.
O

C

N

N
41

42a

C

O

+ H2N

HN

Proc

Proc
NH H
CH2Cl2
N
RT, 15min.

31 Proc=Boc
32 Proc=Tfa
NH2 H H
TFA
N N
CH2Cl2 +
CH3CN
O
(1:1)

Figure 3.32 Synthesis of trimer 43
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H
N
O

H
N
O
43

H
N

H HN
N

O
42a Proc=Boc
42b Proc=Tfa
H NH2
N

Proc

1-((1R,2R)-1-N-t-butyloxycarbonylamino-2-cyclohexyl)-3-[3-(3-(1R,
2R)-1-N-t-butyloxycarbonylamino-2-cyclohexylureido) phenyl] urea [42a]:
H NMR (400MHz, CDCl3 + CD3OD at 40oC): 7.23 (t, 1H, J=2.0 Hz),

1

7.18(t, 1H, J=8.0 Hz), 7.06(dd, 2H, J=8.0, 2.0 Hz), 3.44(m, 2H), 3.20 (m, 2H), 2.0
(m, 4H), 1.78 (m, 4H), 1.37 (s, 18H), 1.15 -1.34 (m, 8H)

13

C NMR (100MHz,

CDCl3 + CD3OD at 40oC): 157.5, 157.0, 139.8, 129.0, 112.5, 108.8, 78.5, 54.3,
53.0, 33.3, 26.8, 24.2.
1-((1R,2R)-1-N-(2-amino-cyclohexyl)-2,2,2-trifluoroacetamide)-3-[3-(3(1R, 2R)-1-N-t-butyloxycarbonylamino-2-cyclohexylureido)phenyl] urea
[42b]:
1

H NMR (400MHz, DMSOd6): 9.18 (d, 2H), 8.18 (bs, 2H), 7.15 (t, 1H,

J=2.01Hz), 6.9-7.2 (m, 3H), 5.95 (d, 2H), 3.55-6.20 (m, 4H), 1.6-2.00 (m, 8H),
1.2-1.7 (m, 8H). 13C NMR (50MHz, DMSOd6): 156.4, 155.7, 155.2, 140.7, 128.8,
118.9, 110.8, 107.0, 53.8, 51.6, 32.6, 31.0, 24.5, 24.2
1-((1R,2R)-1-amino-2-cyclohexyl)-3-[3-(3-(1R, 2R)-1-N-amino-2cyclohexyl ureido) phenyl] urea [42]: To a solution of 42a (87.0 mg, 0.15
mmol) in chloroform: acetonitrile (3.0 mL, 1: 1) was added a solution of
trifluoroacetic acid (25 µl, 0.33 mmol) at RT and stirred for 2h. Triethylamine (46
µl, 0.33 mmol) was added to the reaction mixture to neutralize the TFA. It was
then washed with the brine. The organic phase was dried (Na2SO4) and on
evaporation a white solid was obtained (.12 mmol, 47mg, 79%).
The compound 43 can also obtained by deprotecting 42b by its reaction
with the Ba(OH)2 in quantitative yield.
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1

H NMR (400MHz, D2O + DCl): 7.29 (1H, t, J=2.4 Hz), 7.23 (t, 1H, J=8.4

Hz), 6.96 (dd, 2H, J=8.4, 2.4 Hz), 3.56-366 (m, 2H), 2.95-3.08 (m, 2H), 1.68-2.08
(m, 8H), 1.20-1.50 (m, 4H) 13C NMR (50 MHz, CD3OD): 158.2, 141.2, 130.3,
114.4, 112.4, 56.7, 56.3, 34.9, 33.8, 26.6, 25.8.
3.6.8 Synthesis of pentamer (44)
CF3
O
HN
O
O

C

N

N

C

O

NH
NH
O

34

HN
HN
O HN

HN
HN

NH
O
HN

41
44
H2N
O

.2 M BaOH/MeOH

F3C
O

NH
NH
O

HN
HN
O HN

HN
HN

NH
O
H2N

45

Figure 3.33 Synthesis of Pentamer 44, 45
To the solution of dimer (34) in chloroform was added the 1,3-phenylene
diisocyanate (41) in one lot. It was stirred for 10 min at RT. The solvent was
removed and the residual thick gel was triturated with the dry ether to give the
white solid in quantitative yield.
1

H NMR (400 MHz, DMSOd6): 9.29 (d, 2H, J=7.2 Hz), 8.14 (bs, 2H), 7.35

(bs, 1H), 6.94-7.30 (m, 3H), 5.8-6.00 (m, 5.56), 3.20-3.45 (m, 8H), 1.75-1.96 (m
8H), 1.56-1.68 (m, 8H), 1.10-1.40 (m, 16H). 13C NMR (50MHz, DMSOd6): 158.5,
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156.0, 155.6, 154.9, 140.8, 128.6, 110.4, 106.7, 55.2, 52.7, 52.3, 51.5, 32.2,
30.7, 24.2, 24.0. IR (KBr Pellet) cm-1: 3320.9(s), 2936.3(s), 2859.5(w),
1702.4(m), 1649.6(m), 1562.3(s), 1492.9(w), 1317.8(w), 1317.8(w), 1206.0(s)
3.7 Addendum
3.7.1 Future work
Work on this project will continue with the synthesis of more oligomers of
29. Solution phase synthesis of these oligomers is being pursued using pnitrophenylchloroformate as an activating agent. The p-nitrophenylcarbamate
intermediates are more stable than the isocyanate intermediate produced
through the phosgene equivalents triphosgene and carbonyldiimidazole. If the
stability of the p-nitrophenylcarbamate intermediates is high enough then they
will be purified, and reacted pure with another free amine. Under these conditions
purity of the products should be high.
Oligomers will be studied under cosolvent conditions to determine if the
materials will form helical structures. If it can be shown that the oligomers do
form a helix, oligomers of varying length will be analyzed for helix formation.
Coopertivity in the formation of the helix can be established through establishing
a pattern of increasing ability to form a helix in solution.
3.7.2 Membrane sensors
Berrocal et al. tested the t-Boc-protected pentamer 39 for use as an
ionophore in a liquid membrane sensor system. In this paradigm an ionophore
acts as an embedded binding site that changes the electric potential across a
membrane in the presence of the appropriate analyte above threshold
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concentration. A first evaluation of these compounds as ionophores in anionselective electrodes, indicated some selectivity for sulfate among the tested
hydrophilic anions. However, the response was much larger to more hydrophobic
anions such as salicylate and thiocyanate. Hopefully, with a longer oligourea a
more selective ionophore can be found.
3.8 Conclusion
Analysis of the oligomer 29 was encouraging for further development of
the project. Modeling studies indicated the preference for β-structure from the RC
plots but did not rule out the possibility of α-helix formation. A structure that can
mimic the 2-state structure of proteins will be exciting to investigate, and may
uncover what characteristics are unique to proteins. The preference for βstructure was surprising. Comparisons with the structurally related cyclohexane
β-amino acid led to the assumption that the materials would be helical. However,
the presence of the β-state does not indicate that these materials will not bind to
oxoanions as planed. The helix was the second largest energetic local minimum.
In addition, oxoanions present multiple hydrogen bond acceptors and the
modeled materials were stable and flexible in a Monte Carlo simulation in
chloroform. Hopefully, cosolvents like TFE and HFIP that induce helicity in
peptides will induce similar conformational changes in oligoureas.
Binding was indicated by the NMR and CD analyses. Two separate
binding constants were found in both the NMR and the CD analysis. Additional
measurements of the binding with a less acidic anion are required to discount the
possibility of acid base reactions influencing the results, and decrease error
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measurements that might cast doubt upon the binding determination. Modeling
studies suggest a mechanism for the increased CD absorbance upon formation
of the 1: 1 complex of phosphate and the amide pentamer versus the complex of
phosphate and the urea pentamer. We have found a mechanism of creating a
foldamer that should exploit the additive powers of multiple weak hydrogen
bonds, by creating a foldamer that could do what most de novo binding
molecules do not do. Strongly bind to an oxoanion.
We synthesized two derivatives of 2-aminobenzimidazole that have an
intramolecular hydrogen bond in a conjugated CN system. The synthesis
methodology was simple if not high yielding. Products required only 1 or 2 steps
to get from starting material to product. The compounds were not complex for
either material, but showed interesting dynamics.
The hydrogen bonds that were studied showed a complexity that defies
the common perception that the intramolecular hydrogen bond is a simple tether
linking the hydrogen bond donor and acceptor. Weak hydrogen bonds were
found in guanidinobenzimidazole, that had an effect on the bond order of a
conjugated system. In 1d,e another conjugated system was found with similar
dynamics, but was stericly inhibited from forming an intramolecular hydrogen
bond. The carboxamidine NH hydrogen atom was postulated to have very slow
proton exchange due to the higher pKa of the carboxamidine moiety. This
presented the opportunity to investigate hydrogen bonds in general.
Two different alkylation patterns were analyzed for differences and
similarities in the dynamic rate of exchange of alkyl and benzo protons in an
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effort to determine the mechanism and effect of the intramolecular hydrogen
bond for this conjugated system. A system was made for which the guanidine
nitrogen atoms are either primary or secondary to limit the number of
mechanisms that explain an apparent change in the bond order of these
guanidinobenzimidazole derivatives.
These studies provided a realistic vision of what to expect of
intramolecular hydrogen bonds in the control of de novo designed conformations.
It was found that, the six-centered intramolecular hydrogen bonds studied here
were not necessarily stable enough to be used for the design of compounds
needing conformational stability. In 1d,e the sigma bond at N1-C11 has hindered
rotation from the steric barrier present in a totally planar conformation. Molecules
1b,c had no hindered rotation at C2-N10 except for the intramolecular hydrogen
bond. It appeared that the more planar molecule had an increased effect upon
the bond order of the conjugated system.
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Appendices
A.1 Crystal data and structure refinement for 1c, 1d, 33.

Compound

1c

1d

33

Empirical formula

C14H21N5

C14H21N5

C20H33N4O4F3

Formula weight
Temperature (K)
Wavelength (Å)
Crystal system,
space group
Unit cell
dimensions
a(Å)
b(Å)
c(Å)

259.36
173(1)
0.71073
Monoclinic,
P 21/n

259.35
173(1)
0.71073
Orthorhombic,
P na21

450.5
145(1)
0.71073
Triclinic,
P1

9.6450(10)
7.7760(10)
18.874(3)

18.066(4)
10.234(2)
22.275(5)

4.9590(10)
11.218(2)
11.410(2)

α(o)

90

90

109.04(2)

β(o)

95.559(10)

90

91.77(2)

γ(o)

90

90

101.38(2)

V(Å3)
1408.9(3)
4118.4(14)
585.09(19)
Z, Calculated
4, 1.223
8, 1.121
1, 1.279
density (Mg/m3)
Absorption
0.077
0.075
0.105
coefficient (mm-1)
F(000)
560
1504
240
Crystal size (mm) 0.28 x 0.24 x 0.12 0.44 x 0.30 x 0.30 0.60 x 0.10 x 0.03
θ range for data
2.29 to 25.00
1.83 to 22.50
1.90 to 25.00
collection
-11K
-19K
-5K
Limiting indices
-9N
-11N
-13N
-22O
-23O
-13O
Reflections
9104 / 2479
19888 / 5371
4031 / 4031
collected / unique [R(int) = 0.0548]
[R(int) = 0.0762]
[R(int) = 0.0420]
Completeness to θ = 25.00, 99.9% to θ = 22.50, 99.9% to θ = 25.00, 100%
Absorption
None
None
None
correction
Refinement
Full-matrix leastFull-matrix leastFull-matrix leastmethod
squares on F2
squares on F2
squares on F2
116

Data / restraints /
parameters
Goodness-of-fit on
F2
Final R indices
[I>2sigma(I)]
R indices (all data)

2479 / 48 / 177

5371 / 417 / 451

4031 / 267 / 281

1.092

1.116

1.076

R1 = 0.0676,
wR2 = 0.1381
R1 = 0.0870,
wR2 = 0.1466

R1 = 0.0737,
wR2 = 0.1638
R1 = 0.0908,
wR2 = 0.1728

R1 = 0.0535,
wR2 = 0.0865
R1 = 0.0729,
wR2 = 0.0918
-0.9(7)
[meaningless !]

Absolute structure
NA
parameter
Extinction
0.007(3)
coefficient
Largest diff. peak
0.455 and -0.248
and hole (e Å-3)

0
NA

0.027(3)

0.228 and -0.239

0.197 and -0.151
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A.2 Crystal data and structure refinement for 1g.

Compound

Empirical formula
Formula weight
Temperature (K)
Wavelength (Å)

C14 H21 N5
259.36
173(1) K
0.71073 A
"Monoclinic, P

Crystal system,
space group

21/c"

Unit cell dimensions
a(Å)
b(Å)
c(Å)

8.0810(3)
21.1140(7)
9.6270(3)

α(o)

90 deg.

β(o)

114.2021(14)

γ(o)

90 deg.

V(Å3)

1498.21(9)

Z, Calculated
density (Mg/m3)
Absorption
coefficient (mm-1)

4, 1.150

F(000)
Crystal size (mm)
θ range for data
collection

0.073
560
0.26 x 0.25 x 0.20
1.93 to 27.49 deg.
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-10<=h<=10
Limiting indices

-27<=k<=26
-12<=l<=12

Reflections
collected / unique
Completeness

11517 / 3457
100.00%
Semi-empirical

Absorption
correction

from equivalents
Full-matrix least-

Refinement method
Data / restraints /
parameters
Goodness-of-fit on
F2

squares on F^2
3457 / 0 / 177
1.032
R1 = 0.0497

Final R indices
[I>2sigma(I)]

wR2 = 0.1146
R1 = 0.0784

R indices (all data)
Absolute structure
parameter
Extinction
coefficient
Largest diff. peak
and hole (e Å-3)

wR2 = 0.1262
NA
0.014(2)
.294 and -.284
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A.3 Crystal coordinates (X 104) for 33.

C(1)
C(2)
C(3)
C(4)
C(5)
C(6)
C(1')
C(2')
C(3')
C(4')
C(5')
C(6')
N(7)
C(8)
N(9)
O(10)
N(11)
C(12)
O(13)
C(14)
O(15)
C(16)
C(17)
C(18)
N(19)
C(20)
C(21)
O(22)
F(23)
F(24)
F(25)

x

y

z

U(eq)

6083(5)
4826(5)
4542(6)
2849(6)
4000(6)
4283(5)
7568(5)
6493(5)
7482(5)
6653(6)
7653(6)
6667(5)
6426(4)
5356(5)
7276(4)
2869(3)
6472(4)
8969(5)
8782(3)
11308(5)
11122(3)
12772(6)
10166(6)
13079(5)
6677(4)
8438(5)
7193(6)
10943(4)
8365(3)
4500(3)
7582(4)

1003(2)
508(2)
-942(2)
-1652(2)
-1143(3)
308(2)
2966(2)
3413(2)
4869(2)
5595(3)
5123(3)
3664(2)
1207(2)
1950(2)
2717(2)
1942(2)
2389(2)
3176(2)
4408(2)
5435(2)
2807(2)
5173(3)
6639(3)
5544(3)
1563(2)
796(2)
-647(3)
1153(2)
-1267(2)
-953(2)
-1130(2)

6220(2)
7231(2)
6860(2)
5608(2)
4605(2)
4979(2)
12615(2)
11588(2)
11938(2)
13207(3)
14206(2)
13863(2)
8435(2)
9419(2)
10384(2)
9439(1)
6587(2)
7008(2)
7527(2)
8068(3)
6907(2)
9109(3)
8576(4)
7040(3)
12253(2)
12030(2)
11530(3)
12165(2)
12134(2)
11609(2)
10339(2)

26(1)
28(1)
40(1)
45(1)
41(1)
35(1)
28(1)
28(1)
37(1)
42(1)
40(1)
35(1)
30(1)
26(1)
31(1)
31(1)
28(1)
27(1)
41(1)
37(1)
40(1)
47(1)
79(1)
43(1)
31(1)
34(1)
43(1)
60(1)
82(1)
55(1)
84(1)

________________________________________________________________________
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A.4 Crystal coordinates (X 104) for (1c)
x
N(1)
C(2)
N(3)
C(4)
C(5)
C(6)
C(7)
C(8)
C(9)
N(10)
C(11)
N(12)
N(13)
C(14)
C(15)
C(16)
C(17)
C(18)
C(19)

469(2)
434(2)
1671(2)
3929(3)
4522(3)
3777(3)
2408(3)
1794(2)
2565(2)
-580(2)
-1773(3)
-2709(2)
-2101(2)
-2313(3)
-3965(3)
-3677(3)
-5099(3)
-1879(3)
-3401(3)

y
-509(2)
571(3)
1437(3)
1303(3)
448(3)
-766(3)
-1158(3)
-322(3)
893(3)
899(3)
50(3)
354(3)
-1072(3)
1555(4)
-684(3)
-2583(3)
-340(4)
571(4)
2869(4)
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z
8024(1)
7472(1)
7459(1)
8265(1)
8862(1)
9213(1)
8982(1)
8380(1)
8030(1)
6943(1)
6902(1)
6325(1)
7404(1)
5759(1)
6151(1)
6033(1)
6627(2)
5121(2)
5561(2)

U(eq)
27(1)
27(1)
30(1)
36(1)
38(1)
36(1)
30(1)
25(1)
26(1)
31(1)
29(1)
34(1)
36(1)
41(1)
36(1)
44(1)
49(1)
61(1)
52(1)

A.5 Crystal coordinates (X 104) for (1d)

x

N(1A)
C(2A)
N(3A)
C(4A)
C(5A)
C(6A)
C(7A)
C(8A)
C(9A)
N(10A)
C(11A)
N(12A)
C(13A)
C(14A)
C(15A)
N(16A)
C(17A)
C(18A)
C(19A)
N(1B)
C(2B)
N(3B)
C(4B)
C(5B)
C(6B)
C(7B)
C(8B)
C(9B)
N(10B)
C(11B)
N(12B)
C(13B)
C(14B)
C(15B)
N(16B)
C(17B)
C(18B)
C(19B)
O(1C)
O(2C)
C(1C)

2078(2)
2475(3)
3183(2)
3849(3)
3757(3)
3071(3)
2454(3)
2559(3)
3239(3)
2172(2)
1293(3)
1154(2)
422(3)
368(4)
273(4)
801(2)
1032(3)
637(5)
871(4)
4558(2)
4968(3)
5681(2)
6381(3)
6285(3)
5595(3)
4964(3)
5062(3)
5748(3)
4652(2)
3768(3)
3592(2)
2853(3)
2761(4)
2761(3)
3310(2)
3554(3)
3352(3)
3199(4)
2638(3)
1636(2)
1965(4)

y

z

1736(4)
2124(5)
2354(4)
2240(5)
1953(5)
1566(6)
1461(6)
1732(5)
2131(4)
2227(5)
1483(5)
189(4)
-393(5)
-1298(8)
-1114(7)
2348(4)
3697(5)
4597(7)
4014(7)
1969(4)
2408(5)
2533(4)
2098(5)
1719(5)
1376(6)
1434(5)
1826(5)
2179(5)
2682(5)
1798(5)
521(4)
50(5)
-1350(7)
198(8)
2717(4)
4080(5)
4556(6)
4900(6)
3161(6)
1954(4)
3045(6)

263(2)
761(2)
638(2)
-363(2)
-965(2)
-1188(3)
-814(2)
-220(2)
17(2)
1298(2)
252(2)
343(2)
327(3)
-214(4)
901(3)
171(2)
42(3)
452(4)
-597(3)
2201(2)
1723(2)
1838(2)
2803(2)
3393(2)
3616(2)
3264(2)
2674(2)
2440(2)
1186(2)
2234(2)
2252(2)
2434(2)
2255(4)
3106(3)
2250(2)
2307(2)
2934(3)
1819(3)
5472(2)
5351(2)
5490(3)
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U(eq)

43(1)
43(1)
42(1)
47(1)
54(1)
62(2)
53(1)
40(1)
38(1)
61(1)
41(1)
54(1)
54(1)
103(2)
96(2)
49(1)
64(2)
127(3)
80(2)
41(1)
43(1)
45(1)
47(1)
51(1)
56(1)
49(1)
42(1)
41(1)
57(1)
40(1)
50(1)
56(1)
119(3)
84(2)
42(1)
49(1)
70(2)
88(2)
111(2)
92(2)
76(2)

C(2C)
C(3C)
C(4C)
O(1D)
O(2D)
C(1D)
C(2D)
C(3D)
C(4D)

1437(4)
2080(5)
2065(5)
4770(3)
5665(2)
5414(4)
6039(4)
5102(4)
5460(4)

4046(6)
819(8)
642(9)
-1557(5)
-2798(4)
-1774(7)
-988(7)
-3619(8)
-4690(7)
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5658(4)
5181(4)
4575(3)
2174(3)
2532(2)
2237(3)
2006(4)
2782(4)
3098(4)

107(2)
116(3)
132(3)
121(2)
73(1)
81(2)
106(2)
103(2)
112(3)

A.6 Crystal coordinates (X 104) for (1g)
____________________________________________________________
x
y
z
U(eq)
____________________________________________________________
N(1)
5441(2)
2338(1)
5901(1)
29(1)
C(2)
4685(2)
2594(1)
4476(2)
26(1)
N(3)
4758(2)
2196(1)
3420(1)
27(1)
C(4)
5935(2)
1074(1)
3696(2)
36(1)
C(5)
6671(2)
594(1)
4740(2)
41(1)
C(6)
7042(2)
677(1)
6273(2)
43(1)
C(7)
6701(2)
1246(1)
6821(2)
38(1)
C(8)
5966(2)
1727(1)
5772(2)
28(1)
C(9)
5556(2)
1648(1)
4220(2)
27(1)
N(10)
4008(2)
3191(1)
4330(1)
30(1)
C(11)
2704(2)
3376(1)
3020(2)
29(1)
N(12)
1948(2)
3017(1)
1764(1)
32(1)
N(13)
2057(2)
3973(1)
2974(1)
35(1)
C(14)
2595(2)
4375(1)
4325(2)
35(1)
C(15)
2226(3)
5059(1)
3819(2)
51(1)
C(16)
1637(2)
4180(1)
5325(2)
45(1)
C(17)
447(2)
3192(1)
333(2)
35(1)
C(18)
1062(2)
3616(1)
-647(2)
48(1)
C(19)
-404(2)
2588(1)
-499(2)
49(1)
____________________________________________________________
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A.7 NOSEY spectrum for (1d)
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9

8

PULSE SEQUENCE
Relax. delay 1.000 sec
Pulse 45.0 degrees
Acq. time 3.239 sec
Width 6499.8 Hz
64 repetitions
OBSERVE H1, 299.9418945 MHz
DATA PROCESSING
FT size 65536
Total time 4 min, 32 sec

Solvent: Acetone
Ambient temperature
File: pw132c_purified
INOVA-500 "caribe"

Pulse Sequence: s2pul

126

6.951

7

6.940

7.203

2.00
2.02

7.212

7.222

7.232

pw132a tubes 9,12 2nd recrystalization

6

5

4

3.059

6.23

3

2.050

2

1

ppm

A.8 N-(1H-benzoimidazol-2-yl)-N’,N’-dimethyl-guanidine 1H NMR (300 MHz;
acetone)

2.035

2.043

2.064

2.057

6.931

6.920

A.9 N-(1H-benzoimidazol-2-yl)-N’,N’-dimethyl-guanidine 13C NMR (75.4 MHz;
MeOH)

127

9

8

PULSE SEQUENCE
Pulse 58.5 degrees
Acq. time 1.994 sec
Width 3000.3 Hz
64 repetitions
OBSERVE H1, 199.9247284 MHz
DATA PROCESSING
FT size 16384
Total time 2 min, 8 sec

Solvent: CDCl3
Ambient temperature
File: diisopro_gb_10_3_2ndtry
INOVA-500 "caribe"

Pulse Sequence: s2pul

7

diisopropyl gb 6* freeze pump thaw,
done 10/3/97 2nd nmr of the day for this sample
conclusion small impurity not EtOAc

6

5

4

3

2

1

ppm

A.10 2-Amino-1-benzimidazole-N,N’-diisopropylcarboxamidine 1H NMR (300
MHz; CDCl3)
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180

160

PULSE SEQUENCE
Pulse 60.0 degrees
Acq. time 1.815 sec
Width 16501.7 Hz
16384 repetitions
OBSERVE C13, 75.4200439 MHz
DECOUPLE H1, 299.9414062 MHz
Power 30 dB
continuously on
WALTZ-16 modulated
Single precision data
DATA PROCESSING
Line broadening 1.0 Hz
FT size 65536
Total time 8 hr, 18 min, 36 sec

Solvent: CDCl3
Ambient temperature
File: pw137deacetate_C
INOVA-500 "caribe"

Pulse Sequence: s2pul

140

122.641

120.578

120

116.718

cry of diisopropyl gb that have been desolvated of ethyl acetate

100

77.652

80

60

40

20

ppm

A.11 2-Amino-1-benzimidazole-N,N’-diisopropylcarboxamidine 13C NMR

(75.4 MHz; CDCl3)

129

24.071

77.232

76.811

9

0.96

8

PULSE SEQUENCE
Relax. delay 1.000 sec
Pulse 46.1 degrees
Acq. time 3.245 sec
Width 5000.0 Hz
64 repetitions
OBSERVE H1, 299.9403381 MHz
DATA PROCESSING
FT size 65536
Total time 4 min, 32 sec

Solvent: CDCl3
Temp. 35.0 C / 308.1 K
File: pw2-103-p35
INOVA-500 "caribe"

Pulse Sequence: s2pul

1.79

130
1.88

7

pw2-103 cdcl3 nndiiprgb pure cry 35.0 deg C

6

5
2.00

4

3

2
11.31

1

ppm

A.12 N-(1H-benzoimidazol-2-yl)-N’,N’-diisopropyl-guanidine 1H NMR (300
MHz; CDCl3)

180

160

PULSE SEQUENCE
Pulse 60.0 degrees
Acq. time 3.000 sec
Width 16501.7 Hz
1416 repetitions
OBSERVE C13, 75.4200058 MHz
DECOUPLE H1, 299.9414368 MHz
Power 30 dB
continuously on
WALTZ-16 modulated
Single precision data
DATA PROCESSING
Line broadening 1.0 Hz
FT size 131072
Total time 13 hr, 42 min, 8 sec

Solvent: Benzene
Ambient temperature
File:
INOVA-500 "caribe"

Pulse Sequence: s2pul

13C OBSERVE

140

120

100

80

60

40

20

ppm

A.13 N-(1H-benzoimidazol-2-yl)-N’,N’-diisopropyl-guanidine 13C NMR (75.4
MHz; Benzene)

131

9

8

PULSE SEQUENCE
Pulse 31.5 degrees
Acq. time 3.735 sec
Width 4497.9 Hz
64 repetitions
OBSERVE H1, 399.9291382 MHz
DATA PROCESSING
FT size 65536
Total time 3 min, 59 sec

Solvent: CDCl3
Temp. 35.0 C / 308.1 K
File: pw2-86s2cdcl3-35
INOVA-500 "caribe"

Pulse Sequence: s2pul

STANDARD 1H OBSERVE

7

6

5

4

3

2

1

ppm

A.14 2-Amino-1-benzimidazole-N’,N’-ditolylcarboxamidine 1H NMR (300
MHz; CDCl3)

132

A.15 2-Amino-1-benzimidazole-N’,N’-ditolylcarboxamidine 13C NMR (75.4
MHz; CDCl3)

133

A.16 N-(1H-benzoimidazol-2-yl)-N’,N”-diisopropyl-guanidine (1g) 13C NMR
(100 MHz; CD3OD)

134

A.17 N-(1H-benzoimidazol-2-yl)-N’,N”-diisopropyl-guanidine (1g) 13C NMR
(399.7 MHz; CD3OD)

pw3-121 cry from EtOAc
1H Axis = ppm Scale = 161.45 Hz/cm X 80%

7.500

7.000

6.500

6.000

5.500

5.000

4.500

4.000

3.500

135

3.000

2.500

2.000

1.500

1.000

0.500

0.000

A.18 (33) 1H NMR (399.7 MHz; CDCl3)

136

A.19 (33) 13C NMR (100.5 MHz; CDCl3)

137

A.20 (39) 1H NMR (199.9 MHz; CDCl3)

138

A.21 (39) 13C NMR (50.3 MHz; DMSOd6)
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